Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
Download Please address all correspondence to
Document related concepts
no text concepts found
Transcript
North of England Cancer Research Network – North North of England Cancer Research Network - North Constitution The North of England Cancer Research Network– North operates as part of the NIHR NCRN in England. It is part of the National Institute for Health Research and forms part of the UK Clinical Research Network. The networks support and deliver high quality clinical research studies.NECRN-North Constitution 2012 1 Revision Due: August 2013 Version Control THIS IS A CONTROLLED DOCUMENT PLEASE DESTROY ALL PREVIOUS VERSIONS ON RECEIPT OF A NEW VERSION. VERSION DATE ISSUED 2 19 August 2011 3 30 August 2012 OWNER’S NAME BRIEF SUMMARY OF CHANGE P.7. Hexham General Hospital added P.8. Research now reports to each Network Board Meeting Appendix 5 . At Risk posts prioritised for FSF funding P.4 Lead Clinician NECN Dr Anthony Branson P.5 Updated Trust managerial representatives P.8 Comment re Newcastle as PTC for Paediatric Oncology and TYA also ref to QE and SRH as designated TYA shared cared centres P.9 Ref to RCF Funding P.10 Change of Appendix numbers Bridget Workman Bridget Workman Through this consensually agreed constitution the North of England Cancer Research Network North aims to demonstrate; • That it is a properly constituted and functioning cancer research network • That there are effective processes in place for evaluating participation in clinical trials and other . well designed studies across the network and identifying points for improvement • That effective processes for engaging with your Cancer Network to highlight priorities and barriers/challenges to the delivery of good quality research The North of England Cancer Research Network– North operates as part of the NIHR NCRN in England. It is part of the National Institute for Health Research and forms part of the UK Clinical Research Network. The networks support and deliver high quality clinical research studies.NECRN-North Constitution 2012 2 Contents Page 1. Agreements / Cover Sheet 3 2. Introduction 7 3. Network Organisation 8 4. Reporting Arrangements 8 5. Integration with Cancer Service 9 6. Integration with other Research Infrastructure 9 7. Steering Group 9 8. Financial Arrangement 9 9. Service Level Agreement 9 10. List of Appendices 10 The North of England Cancer Research Network– North operates as part of the NIHR NCRN in England. It is part of the National Institute for Health Research and forms part of the UK Clinical Research Network. The networks support and deliver high quality clinical research studies. NECRN-North Constitution 2012 3 North of England Cancer Research Network – North Constitution Agreement Cover Sheet This constitution has been agreed by: Position NECN Cancer Network Lead Clinician Name Dr Anthony Branson Organisation North of England Cancer Network Date Agreed 24/09/12 Position NCRN Assistant Director Name Dr Matthew Cooper Organisation National Cancer Research Network Date Agreed 24/09/12 Position Clinical Lead of the North of England Cancer Research Network - North Name Dr Anne Lennard Organisation North of England Cancer Research Network – North Date Agreed 24/09/12 The North of England Cancer Research Network– North operates as part of the NIHR NCRN in England. It is part of the National Institute for Health Research and forms part of the UK Clinical Research Network. The networks support and deliver high quality clinical research studies.NECRN-North Constitution 2012 4 Position Chair of the NECN Network Board Name Karen Straughair Organisation South of Tyne PCTs Date Agreed 24/09/12 Trust Managerial Representative Name Organisation Date Agreed Mrs Lorraine Legg County Durham and Darlington NHS Foundation Trust 24/09/12 Mrs Melanie Robertson City Hospitals Sunderland Trust NHS Foundation Trust 24/09/12 Mr Kevin Clarke Gateshead Health NHS Foundation Trust 24/09/12 Mr Andrew Welch Newcastle upon Tyne Hospitals NHS Foundation Trust 24/09/12 Dr Jonathan Nicoll North Cumbria University Hospitals NHS Trust 24/09/12 Dr Bob Stirling Northumbria Healthcare NHS Foundation Trust 24/09/12 Dr Oliver Schulte South Tyneside NHS Foundation Trust 24/09/12 Constitution Review Date August 2013 The North of England Cancer Research Network– North operates as part of the NIHR NCRN in England. It is part of the National Institute for Health Research and forms part of the UK Clinical Research Network. The networks support and deliver high quality clinical research studies.NECRN-North Constitution 2012 5 North of England Cancer Research Network – North North of England Cancer Research Network – North Constitution 1. Introduction The North of England Cancer Research Network–North (NECRN–N) is one of two Research Networks linked to the Service Network (North of England Cancer Network – NECN). The Research Network was one of the first wave research networks established in 2001. It serves a population of approximately 2.0 million. It is hosted by South Tyneside PCT. Network North of England – North. Clinical Lead for Research (10-1A-501) Dr Anne Lennard. Research Network Manager (10-1A-502) Mrs Bridget Workman. Network Population 2.0 million. Network organisation Devolved with some centralised posts Staff appointments Core team part of Cancer Network: Some centralised appointments with honorary contracts in trusts and some trust posts employed by Trusts. Line management Clinical Lead to Network, Medical Director of NECN, Network Manager to Network Director. Centralised posts to Manager and Team Leads. Local line managers identified in each trust – mix of Cancer Services and R&D. Governance NCRN team members link to Trust R&D Departments and CLRN for R&D processes. Submissions are devolved. Portfolio management NECRN Core Team support and guide trusts with Portfolio development and management. NSSGs will review trials portfolios and provide comments The North of England Cancer Research Network– North operates as part of the NIHR NCRN in England. It is part of the National Institute for Health Research and forms part of the UK Clinical Research Network. The networks support and deliver high quality clinical research studies.NECRN-North Constitution 2012 6 Summary of NHS organisations within the network from which patients are recruited (or referred) Trust name Trust Hospital site(s) Hospital site acronym acronym County Durham and CDDFT University Hospital North Durham UHND Darlington NHS Foundation Trust City Hospitals CHSFT Sunderland Royal Hospital SRH Sunderland Trust NHS Foundation Trust Gateshead Health NHS GHFT Queen Elizabeth Hospital QE Foundation Trust North Cumbria NCUHT Cumberland Infirmary CI University Hospitals NHS Trust North Cumbria NCUHT West Cumberland Hospital WCH University Hospitals NHS Trust Northumbria Healthcare NHFT Hexham General Hospital HGH NHS Foundation Trust Northumbria Healthcare NHFT North Tyneside General Hospital NTGH NHS Foundation Trust Northumbria Healthcare NHFT Wansbeck General Hospital WGH NHS Foundation Trust Newcastle upon Tyne NUTHFT Freeman Hospital FH Hospitals NHS Foundation Trust Newcastle upon Tyne NUTHFT Royal Victoria Infirmary RVI Hospitals NHS Foundation Trust Newcastle upon Tyne NUTHFT Institute of Human Genetics IHG Hospitals NHS Foundation Trust South Tyneside NHS STFT South Tyneside District Hospital STDH Foundation Trust Summary of PCTs covered by Network area (to give indication of geographical boundaries) PCT name PCT name Northumberland Care Trust Newcastle PCT Gateshead PCT County Durham PCT Cumbria PCT North Tyneside PCT South Tyneside PCT Sunderland Teaching PCT Other Networks in our locality Stroke Research Network – North East; Diabetes Research Network – North and East Cumbria; Mental Health Research Network – North East Hub; Dendron – North East; Primary Care Network – Northern & Yorkshire. Comprehensive Local Research Network(s) County Durham & Tees Valley Comprehensive Research Network Lancashire and Cumbria Comprehensive Research Network Northumberland Tyne and Wear Comprehensive Research Network Cancer Research Network Trust included CDDFT NCUHT CHSFT GHFT NHFT NUTHFT STFT The North of England Cancer Research Network– North operates as part of the NIHR NCRN in England. It is part of the National Institute for Health Research and forms part of the UK Clinical Research Network. The networks support and deliver high quality clinical research studies.NECRN-North Constitution 2012 7 2. Network Organisation The North of England Cancer Research Network–North (NECRN–N) is one of two Research Networks linked to the Service Network North of England Cancer Network (NECN). The Research Network was one of the first wave Research Networks established in 2001. Prior to this the main research activity was centred at Newcastle Upon Tyne Hospitals NHS Trust. The Queen Elizabeth Hospital in Gateshead coordinated most of the Gynaecology research and a small portfolio of other trials. Cumbria had established a small portfolio of trials and with little help recruited to some well. Other Hospitals in the Network had little in the way of clinical trial activity with limited or no support. We are one of the largest Networks in geographical terms, covering an area from Whitehaven on the West Coast of Britain across to Newcastle upon Tyne on the East Coast, and from Berwick upon Tweed on the Scottish border down to Durham. The area served by NECN North provides for a population of just over 2 million and includes 7x Hospital Trusts and 8x PCTs. Radiotherapy services are provided in Newcastle and Carlisle, whilst each of the Acute Hospital Trusts provides a chemotherapy service. Newcastle Upon Tyne Hospitals Foundation Trust is the specialist centre Oncology/Haematology services, Hepatobilary, Testicular and Sarcoma services as well as Thoracic Surgery. Newcastle is the level 4 Haematology centre for Transplants. It is also the Principle Treatment centre for Paediatric Oncology and Teenagers and Young Adults (TYA). Gateshead Health NHS Foundation Trust is the Gynaecological Oncology Specialist Centre and designated shared care centre for TYA in this speciality . City Hospitals Sunderland is the centre for Penile Cancers as well as a level 3 Haematology service. And also a designated shared care centre for TYA in haematology. The NECRN-N continues to support a research infrastructure across the northern half of the Service Network. Each Trust now has a portfolio of Trials and support to coordinate them. The model employed is principally a devolved one although a number of staff have centralised contracts. This gives the flexibility to move staff to cover across the network. An organisation chart showing the staff supporting NIHR cancer trials and links to the service network can be found as Appendix 1 There are staff funded from Comprehensive Local Research Networks (CLRNs), charitable and commercial funds working across the network who support NCRN trials as well as non NIHR commercial, local and translational research. Newcastle is an Experimental Cancer Medicine Centre (ECMC) which aims to increase the interactions between experts from the full range of cancer research and treatment disciplines (surgery, pathology, imaging, adult and Paediatric oncology), so that new cancer treatments are developed in the most informative and expeditious manner to bring benefit to patients. The Centre has PET and MRI imaging facilities and pharmacology and pharmacodynamic assessment laboratories. 3. Reporting arrangements The North of England Cancer Research Network–North (NECRN–N) is an integral part of the North of England Cancer (Service) Network (NECN) with the Manager and Clinical Lead of the Research Network being directly responsible to the Cancer Network Director and Medical Director respectively. The Clinical Lead has an annual review by the Medical Director of the Cancer Network. Appendix 2 shows the Clinical Leads responsibilities NECRN–N reports all to the Cancer Network Board meetings and the Clinical Lead is a member of the Board; the research manager will deputise if she is unable to attend. Appendix 3 shows the membership and terms of reference for the Network board The Clinical Lead and Research Network Manager are also accountable to the National Cancer Research Network (NCRN) Network Director and Assistant Directors who are involved in performance management of the Research Network. The Annual Report is the Network’s process for reporting to the NCRN CC and thus the performance management tool for the network. This is distributed locally to all key stakeholders including the Network Board, all Network Groups, and key personnel within Acute Trusts, Cancer Researchers and R&D departments by email and posted on the NECN website. The distribution list can be found in the NECRN-N Annual Report Appendix 3B. 4. Integration with Cancer Service The North of England Cancer Research Network– North operates as part of the NIHR NCRN in England. It is part of the National Institute for Health Research and forms part of the UK Clinical Research Network. The networks support and deliver high quality clinical research studies.NECRN-North Constitution 2012 8 In addition to the direct reporting arrangements described earlier, the Research Network Manager has 1:1 meetings with the NECN Director. The Research Network Clinical Lead is a member of the NECN Network Board. The Network Director and Medical Director are part of the Research Executive Steering group which both North and South NECN Research Networks feed into and is an over arching group for both Steering Groups. The Research Network Manager is a member of both the Lead Nurses and Cancer Managers group of the service network. She is also on the membership of the Network Chemotherapy and Pharmacy group. Attendance at Network Site Specific groups (NSSGs) is shared between both North and South Research Network Managers who represent; both Research Networks to ensure that there is research representation at every meeting and research and trials are standing items on the agendas. An update on recruitment and the portfolio is submitted to every NSSG. In addition, a standard template is provided for the NSSG to complete its agreed list of trials as well as reports of recruitment activity and study portfolio. A Corresponding template is provided to the MDTs. These templates will support their discussions and agreement of remedial actions. Two members of the NECN Patient & Carer group are on the NECRN-N Steering Group. 5. Integration with other research infrastructure The Research Network Clinical Lead is a member of the Northumberland Tyne and Wear CLRN Board. Clinical Leads in NECRN-S and Lancashire and South Cumbria Research Network represent our interests on the Durham and Tees Valley CLRN and Cumbria and Lancashire CLRN respectively. This Research Network is part of the Northern Regional group for NCRN Managers and there is representation on the Northern Region Training and Education group. The Network Manager also attends meetings with other Topic Network Managers through the CLRN. 6. Cancer Research Steering Group The NECRN–N Steering group currently meets on a six monthly basis. Membership consists of NECRN-N Core staff, the Service Network Medical Director and Director, Head of Service Reform, Nursing Modernisation Manager Pharmacy Consultant, two User representatives, representation from all Trusts, Director of the ECMC unit, and representation from Northumberland Tyne and Wear CLRN. The role of this group is to give strategic direction to the Cancer Research Network to improve recruitment to clinical trials and other well designed studies. It oversees financial allocations and resources and reviews activity across the network. The Terms of reference and group membership are listed in Appendix 4. 7. Financial Arrangements South Tyneside PCT is our host organisation and core network funding is allocated from the Department of Health to us on behalf of the NCRN. The Network provides NCRN with annual finance plans, mid year reports and end of year reports. Research and Capability Funding (RCF) is also provided annually to enable networks to maintain research capacity. Allocation will be agreed at either the Steering group or a dedicated sub-group of this group. 8. Service Level Agreement Service level agreements are agreed with member organisations. The SLA details the expectations placed on both the research Network and the Trust. Copies of the SLAs appear in Appendix 5. These are reviewed every two years by the Research Network Core Team. The North of England Cancer Research Network– North operates as part of the NIHR NCRN in England. It is part of the National Institute for Health Research and forms part of the UK Clinical Research Network. The networks support and deliver high quality clinical research studies.NECRN-North Constitution 2012 9 9. Appendices Appendix 1 Organisation Chart Appendix 2 Clinical Lead Responsibilities Appendix 3 Cancer Network Board TOR Appendix 4 Research Network Steering Group TOR Steering Group Membership Appendix 5 Service level Agreements Appendix 6 Contact details for Cancer Research Network Team (Clinical Lead for Research and Research Network Manager). Appendix 7 Contact point for consumer involvement- Contact details for Cancer Network Team (Medical Director, Director, and Nurse Director) Appendix 8 Contact details for Leads for each cancer site corresponding to NCRI Clinical Study (Development) Groups. Appendix 9 Network Clinicians who are members of NCRI Clinical Study (Development) Groups Appendix 10 Comprehensive Local Research Network Directors and Senior Managers Appendix 11 CRN Host Organisation The North of England Cancer Research Network– North operates as part of the NIHR NCRN in England. It is part of the National Institute for Health Research and forms part of the UK Clinical Research Network. The networks support and deliver high quality clinical research studies.NECRN-North Constitution 2012 10 Appendix 1 Network Overview and Structure NECN Medical Director Janet Whiteway NCRN Coordinating Centre NECRN-N Network Director Roy McLachlan Administrator 1.0wte NECRN-N Team View Team Leader (North Cumbria Angela Birt 1.0wte CTO North Cumbria 1.0 wte CTA North Cumbria 0.2 wte NECRN-N Research Manager Bridget Workman 1.0wte Team Leader (Newcastle) Chris Barron 1.0wte Administrator 0.2 wte NCCC Freeman Hospital Research Radiographer NECRN-N Clinical Lead for Research Dr Anne Lennard Newcastle Staff Specialist Nurses Primary Care Lead Scott Wilkes Team Leader Julia Scott 0.2 wte 1.0wte CDDFT CTO (UHND) 1.0wte 1.0wte CTA (UHND) 0.4 wte Clinical Trials Officers 3.0wte Research Nurses Oncology 3.0wte CHSFT CTO 1.0wte Clinical Trials Coordinators 2.0wte Research Nurses Urology Paediatrics 6.6wte South of Tyne Data Manager covers: CHSFT. GHFT, STFT Clinical Trials Assistant Data Managers (Paediatrics) 3.0wte GHFT CTO (QE) Trial Coordinators: ECMC Paediatrics 3.0wte 1.0wte 1.0wte Data Managers NCCC 3.0wte Research Nurses 2.0wte 0.1wte Haem Research Nurses 1.5wte 1.0wte 1.0wte Gynae Research Nurse 1.5wte NHT CTO (NT) 1.0wte CTO (WGH) 0.6wte Research Nurse (NT) 0.6wte Research Nurse WGH) 0.4wte CTA 0.5wte STH CTO 1.0wte Research Nurse (Upper GI) 0.2 wte The North of England Cancer Research Network– North operates as part of the NIHR NCRN in England. It is part of the National Institute for Health Research and forms part of the UK Clinical Research Network. The networks support and deliver high quality clinical research studies.NECRN-North Constitution 2012 11 Appendix 2 Clinical Lead Responsibilities North of England Cancer Research Network – North NORTH OF ENGLAND-NORTH CANCER RESEARCH NETWORK Job Description The post will be part-time filled by a consultant with knowledge and experience of cancer and previous experience in cancer clinical trials. Title: Clinical Lead for Research Accountable to: Medical Director, North of England Cancer Network Hours: Part time. 2 Programmed Activity sessions per week. Tenure: Until March 2012 Network Office: NECN, Team Valley, Gateshead Salary: Pro-rata Equivalent at appropriate Consultant level Liaises with: NCRN Director and Coordinating Centre Staff, NECN Cancer (Service) Network Executive, Local Research and Development staff, in particular Trust R&D Directors, Clinical, Managerial and Research Leads within NECN Cancer Network Trusts, Comprehensive Local Research Network Directors and Managers. Network Summary: The North of England Cancer Research Network-North (NECRN-N) was established in 2001 as part of the highly successful National Cancer Research Network (NCRN) initiative. The NCRN, established by the Department of Health, aims to improve the speed, quality, and integration of research, ultimately resulting in improved patient care. NECRN–North is one of the largest Networks in geographical terms, covering an area from Whitehaven on the West Coast of Britain across to Newcastle upon Tyne on the East Coast, and from Berwick upon Tweed on the Scottish border down to Durham. The area served by NECN North provides for a population of just over 2 million and includes 7x Hospital Trusts and 8x PCTs. The Research Network is led by a part time Clinical Lead for Research (this post) and a Research Network Manager who is based at The NECN, Team Valley but works across all Network sites. Role Summary: This post will provide the clinical leadership and development of the Research Network in line with local and national priorities. The post holder will be required to promote the aims of the NCRN ensuring access to clinical trials for patients with cancer, and, in turn, increasing accrual into trials, across the Network. The NIHR North of England –North Cancer Research Network is part of the National Institute for Health Research and the UK Clinical Research Network The North of England Cancer Research Network– North operates as part of the NIHR NCRN in England. It is part of the National Institute for Health Research and forms part of the UK Clinical Research Network. The networks support and deliver high quality clinical research studies.NECRN-North Constitution 2012 12 Responsibilities 1. To provide clinical leadership for the Cancer Research Network in the North of England Cancer Network North, advising the North of England Cancer Network Board on the NECRNN’s role as part of the National Cancer Research Network 2. To oversee the participation of the North of England – North Cancer Research Network in NCRN activities. 3. To liaise with the North of England Cancer Network Medical Director, Director, Head of Service Reform, Nurse Director, Chair of the Commissioning Group and other North of England Cancer Network staff concerning the North of England–North Cancer Research Network’s participation in the NCRN. 4. To represent the cancer research interest at the North of England Cancer Network Board and the Northumberland Tyne and Wear Comprehensive Local Research Network Board. 5. To liaise with existing tumour groups and management groups in the Network and establish other groups as appropriate. 6. With the assistance of the Research Network Manager to develop and maintain an ongoing portfolio of clinical trials, to which patients from the North of England Network area will be recruited. This is to be developed in discussion with the North of England Cancer Network Tumour-Specific Groups and in line with the clinical trial activity of the Network Trust Research and Development programmes and the NCRN. 7. With other members of the North of England–North Cancer Research Network Steering Group to be responsible for the overall recruitment and quality of clinical trial research in the North of England–North Cancer Research Network, ensuring that appropriate governance processes are in place and all clinical trial activity is supported by appropriate guidelines and protocols and complies with established quality standards. 8. With the assistance of the Research Network Manager, to introduce systems to enable the North of England–North Cancer Research Network to comply with NCRN agreed performance, financial and planning arrangements and report on progress in these areas as required. 9. To liaise with the Trust nominated Cancer Research Leads, Chairs of Tumour-Specific Groups and Cancer Lead Clinicians and Research Groups to promote recruitment to clinical trials throughout the Network. 10. To contribute to the recruitment, training, support and quality control of the Research Network Manager, and other research staff at the North of England–North Research Network. 11. To keep abreast of clinical trial developments locally, nationally and internationally and to inform and guide the North of England North Cancer Network accordingly. 12. To represent the North of England–North Cancer Research Network at strategic health authority, regional, national and international meetings. Job Plan The sessional commitment to the Cancer Research Network will be 2 PAs. The timing of these sessions will agree upon appointment. Flexibility will be required by the post holder in order to attend national and local meetings, as required by the post. Full registration with the General Medical Council is mandatory for this post. The appointee should be a fully registered medical practitioner who must be registered with, or eligible for, an appropriate GMC Specialist List. The North of England Cancer Research Network– North operates as part of the NIHR NCRN in England. It is part of the National Institute for Health Research and forms part of the UK Clinical Research Network. The networks support and deliver high quality clinical research studies.NECRN-North Constitution 2012 13 Appraisal Appraisal will be carried out by the employing Trust. The post holder will be subject to annual review by the North of England Cancer Network Medical Director. Person Specification The Clinical Lead would be expected to have the following skills and experience: • Experience of running clinical trials at Phase II and III. • Success in coordination of trials at a national level and good working relationships with national trials development bodies such as the NCRI Clinical Studies Groups. • Established local credibility for commitment to clinical research. • Membership of, or good working relationships with, local units conducting cancer research funded by the major funding bodies. • Experience in holding and administering research grants. • An up to date record of publication in clinical cancer research. • Practical organisational skills. Job Description This job description will be subject to discussion and review on an annual basis within the appraisal process. POST HOLDER'S SIGNATURE: DATE: MANAGER'S SIGNATURE: DATE: The North of England Cancer Research Network– North operates as part of the NIHR NCRN in England. It is part of the National Institute for Health Research and forms part of the UK Clinical Research Network. The networks support and deliver high quality clinical research studies.NECRN-North Constitution 2012 14 Person Specification Essential QUALIFICATIONS EXPERIENCE Desirable How identified Full General Medical Council Registration and on or eligible for appropriate GMC Specialist Register AF/CV/GMC Consultant Member of a multi-disciplinary team in NECN AF/CV Experience of contributing to phase III clinical trials and other well designed studies Experience in holding and administering research grants or similar budgetary experience AF/CV Experience of the Clinical Trials Regulations Commitment to Raising the Value of Recognised Training and Development for all Clinical Researchers AF/CV/Int/Ref Commitment to improve cancer care through integration of research into ‘normal’ practice SKILLS & KNOWLEDGE Strong communication, negotiation and persuasion skills able to influence across professional and organisational boundaries AF/CV/Int Understanding of NHS Cancer Reform Strategy and broader healthcare issues AF/CV/Int/Ref Strategic awareness, ability to function at Board level OTHER REQUIREMENTS Effective team member able to draw on the team for information, ideas, resources and action Int Practical organisational skills Evidence of Recent Learning and Development with respect to clinical trials AF/CV/Int AF/CV/Int Membership of, or good working relationships with, local units conducting cancer research funded by the major funding bodies An up to date record of publication in clinical cancer research CV – Curriculum VitaeAF – Application Form Int – Interview CV/AF/Int Ref – ReferenceGMC- General Medical Council The North of England Cancer Research Network– North operates as part of the NIHR NCRN in England. It is part of the National Institute for Health Research and forms part of the UK Clinical Research Network. The networks support and deliver high quality clinical research studies.NECRN-North Constitution 2012 15 Appendix 3 Network Board Terms of Reference 1. The Board is recognised by its members, the statutory bodies, (strategic health authorities, acute trusts and PCTs) in the Network, as the group to which they delegate corporate responsibility in their governance structure for: - Co-ordination and consistency of Network policy for the commissioning and provision of cancer services - Agreeing cancer services delivery proposals and priorities - Setting the direction of travel for cancer services in the North East SHA and North Cumbria - Ensuring users and their representatives have a strong role in influencing cancer service policies and priorities - Ensuring effective relationships with the independent sector and voluntary sector. The Board remains accountable for clinical and corporate governance to the statutory bodies in the Network. 2. The Board is responsible for providing a strategic framework within which cancer services will develop and within this to set the immediate and longer term priorities. This framework will encompass the whole patient pathway from prevention and screening through the supportive, cancer, and palliative care pathways. This will include ensuring that relevant strategic documents are developed for the Network covering all aspects of “Improving Outcomes; a Strategy for Cancer”, and that these documents are linked to other strategic plans for non-cancer services as appropriate. 3. The Board will set a framework and parameters for the commissioning of cancer services across the Network, recognising the need to balance local Cancer Unit developments with Network wide priorities. 4. Specific responsibilities include:- Provide leadership and innovation in cancer services delivery - Coordinate Cancer Peer Review for the Board and its tumour groups - Promote equity across the Network - Define specific objectives to which NECN groups should work, based on the strategic framework developed and priority setting process - Base decisions and strategic planning on the substantial clinical advice, including specific data regarding clinical outcomes and performance, that is available through the NECN structure, either by the site specific groups/cross cutting groups or Nursing and AHP forums - Manage the Cancer Drug Fund on behalf of the Strategic Health Authority through the North of England Cancer Drugs Approval Group - Manage and act within a robust clinical governance framework - Work closely with partner organisations on strategic issues relating to the cancer workforce and training and education - Undertake service reviews of existing services, in particular where national indicators show that performance on cancer outcomes in the NECN is below the national average - Work closely with other clinical networks and modernisation streams that may have common ground in terms of reviewing patient pathways, and resolving bottlenecks in the pathway, to achieve continuous service improvement - Work in collaboration with external organisations such as the Cancer Action Team, NYCRIS and NCRCN, NEPHO and other networks Drive the service reform agenda in cancer services for all services including treatments and drugs. The North of England Cancer Research Network– North operates as part of the NIHR NCRN in England. It is part of the National Institute for Health Research and forms part of the UK Clinical Research Network. The networks support and deliver high quality clinical research studies.NECRN-North Constitution 2012 16 5. Meetings will be held bi-monthly, although additional meetings may be planned to accommodate specific pieces of work. It is expected that representatives attending meetings will brief colleagues within their organisations as needed. 6. The meetings shall be quorate with attendance from more than half of its constituent organisations. 7. The members must at all times act in a professional and courteous manner and agree to abide by decisions made by the Board. Membership Attached Chair: Karen Straughair, Chief Executive, NHS South of Tyne & Wear R McLachlan Network Director October 2011 The North of England Cancer Research Network– North operates as part of the NIHR NCRN in England. It is part of the National Institute for Health Research and forms part of the UK Clinical Research Network. The networks support and deliver high quality clinical research studies.NECRN-North Constitution 2012 17 Appendix 3 Network Board Members Nominated Representatives and Deputies of the Network Board NECN Chair – Karen Straughair, Chief Executive, NHS South of Tyne & Wear Organisation Nominated Representative SHAs North Cluster Dr Stephen Singleton, Medical Director Trusts City Hospitals Sunderland NHS Foundation Trust County Durham and Darlington NHS Foundation Trust Gateshead Health NHS Foundation Newcastle upon Tyne Hospitals NHS Foundation Trust North Cumbria University Hospitals NHS Trust North Tees and Hartlepool NHS Foundation Trust Northumbria Healthcare NHS Foundation Trust South Tees Hospitals NHS Trust South Tyneside NHS Foundation Trust Nominated Deputy TBA Mark Smith, Director of Strategy & Service Development Tom Dodds, Head of Business Development John McDonald, Lead Clinician Mr David Beaumont, Medical Director Dr Timothy Walls, Medical Director Pauline Burton Mrs Carolyn Harper, Cancer Lead Mr Andy Welch, Lead Clinician Corinne Siddall, Chief Operating Officer Mr Alan Foster, Chief Executive Ms Rosemary Stephenson, Executive Director of Nursing Ms Susan Watson, Operational Services Director Helen Ray, Executive Director Lead, South Tyneside FT Dr Jonathan Nichols Lyne Kirby Louise Shutt, Cancer Unit Manager Ms Elaine Kilgannon , Cancer Services Lead Manager The North of England Cancer Research Network– North operates as part of the NIHR NCRN in England. It is part of the National Institute for Health Research and forms part of the UK Clinical Research Network. The networks support and deliver high quality clinical research studies.NECRN-North Constitution 2012 18 PCTs NHS Cumbria NHS County Durham & Darlington PCT South of Tyne Ms Ros Berry, Specialised Services Commissioner Debbie Edwards Nurse Advisor / Clinical Quality lead, NHS County Durham Mike Procter, Director of Commissioning, Strategy & Procurement Mr John Hancock, Head of Specialist Services and Clinical Networks Anya Paradis Head of Commissioning (Newcastle) Nonnie Crawford Voluntary Sectors St Clares Hospice Patient & Carer Representatives Mr David Hall TBC Network Executive Team Network Director Network Medical Director Network Clinical Lead Network Quality & Patient Safety Director Mr Roy McLachlan Mr Tony Branson Mrs Nicola Storey Sarah Rushbrooke Research Networks Clinical Lead (North) Clinical Lead (South) Anne Lennard- Clinical Lead Research Nick Wadd- Clinical Lead Research Mrs Bridget Workman (Research Manager) Mrs Helen Boal (Research Manager) Other North of England Cancer Network Drug Approval Group (Chair) Mr Ken Bremner, Chief Executive, City Hospitals NHS Foundation Trust Steve Williamson, Consultant Pharmacist Tees PCTs North Yorkshire and York PCT North of Tyne Joanne Dobson Julia Young/Rachel Michison Sheila Alexander The North of England Cancer Research Network– North operates as part of the NIHR NCRN in England. It is part of the National Institute for Health Research and forms part of the UK Clinical Research Network. The networks support and deliver high quality clinical research studies.NECRN-North Constitution 2012 19 Appendix 4 Research Network Steering Group TOR North of England Cancer Research Network - North Steering Committee Terms of Reference Purpose • To ensure the continued development and work of the NCRN in the Northern Cancer Research Network and to advise the NECN board accordingly. Specific Aims • • • • To advise and support the Clinical Lead for Research and the Research Manager; To agree and keep under review the Job descriptions, appointments and roles of the NECN (North) research staff; To continually monitor and develop strategies to influence recruitment to cancer clinical trials in the NECN (North) and performance relative to national NCRN targets; To monitor and review the NCRN ring fenced budget. Membership • • • • • • • • • • • • • Chair (Clinical Lead for Research); Research Manager (North); Clinical Lead for NECN (North); Director NECN; Medical Director NECN; Nurse Director NECN; Network Service Reform Lead; Network Pharmacist NECN (North); Representative Palliative Care; Representative Paediatrics; Representative Haematology; 2 User representatives; A representative from each trust involved in the research Network representing the cancer clinical research inertest of the trust. Accountability • The Research Network will be accountable to the National Cancer Research Network (NCRN) and the North of England Cancer Network Board. Objectives • • • To seek to integrate NCRN portfolio research into the cancer patient pathway in NECN (North); To provide progress reports, discuss and agree strategic plans for the research network, including a fair allocation of funding for research staff and support costs across NECN (North); To agree with each trust appropriate targets for trial entry, monitor individual trust progress on a six monthly basis and provide additional support where appropriate as the information base develops; • To support the Research Network Management Team in achieving the following: • To ensure regular reports and information are provided to the NECN Network Board and NECN Network Tumour Site Specific Groups as to progress and future strategic development; The North of England Cancer Research Network– North operates as part of the NIHR NCRN in England. It is part of the National Institute for Health Research and forms part of the UK Clinical Research Network. The networks support and deliver high quality clinical research studies.NECRN-North Constitution 2012 20 • • • To support the process of gaining regulatory approval for new trials and working with trust research staff to ensure compliance, all aspects of GCP, running of trials (including assisting trust based support services i.e. pharmacy, radiology and pathology), effective recruitment, overcoming barriers to recruitment and problem solving; Develop and implement appropriate IT systems in support of the NCRN trials; Oversee the accessibility of a training and education programme for research staff. Reporting Arrangements • • • • • The Steering Group will meet 2 times per annum; Email important urgent communication between meetings; Meeting minutes will be taken and circulated within the group ; Progress reports will be submitted to the NECN Board; Action plans will be updated at each meeting. Outcomes • Greater equity of service. Dr Phillip Atherton Northern Cancer Research Network Chair June 2007 The North of England Cancer Research Network– North operates as part of the NIHR NCRN in England. It is part of the National Institute for Health Research and forms part of the UK Clinical Research Network. The networks support and deliver high quality clinical research studies.NECRN-North Constitution 2012 21 Appendix 4 Steering Group Membership Name Job Title NECRN - North Email Dr Anne Lennard Clinical Lead for Research Freeman Hospital anne.lennard@nuth.nhs.uk Bridget Workman Research Manager Claire Singleton Patient Representative North of England Cancer Research Network - Bridget.Workman@sotw.nhs.uk North University Hospital of North Durham clare@singleton14.eclipse.co.uk Duncan Leith Primary Care Cancer Lead NNN Mental Health NHS Trust duncanleith@generalpractice.co.uk Fiona Douglas Consultant in Clinical Genetics Institute of Human Genetics f.s.douglas@ncl.ac.uk John Macdonald Consultant Gaenocologist Professor H. Josef Vormoor Dr. Juliet Hale Justine Smith Sir James Spence Chair of Child Health Consultant in Paed and Adolescent Oncology Lead RM&G Manager NTW CLRN County Durham & Darlington Foundation NHS John.Macdonald@cddft.nhs.uk Trust Newcastle University, H.J.Vormoor@ncl.ac.uk Northern Institute for Cancer Research Royal Victoria Infirmary juliet.hale@nuth.nhs.uk Dr Mark Verrill Consultant Med Oncologist Dr Mary Comiskey Consultant in Palliative Medicine Paddy Stevenson NIHR Operations Manager Phyl Wrenray Patient Representative Roy McLachlan Network Director North of England Cancer Network roy.mclachlan@necn.nhs.uk Dr. Ruth Plummer Professor of experimental cancer medicine Clinical Lead, PCRN Northern & Yorkshire Primary Care Lead, NTW CLRN Executive GP/Honorary Clinical Senior Lecturer Sir Bobby Robson Cancer Trials, Research Centre Freeman Hospital Institute of Health & Society Newcastle University Ruth.plummer@nuth.nhs,uk Dr. Scott Wilkes Northumberland, Tyne and Wear CLRN Justine.Smith@nuth.nhs.uk Northern Centre for Cancer Care Freeman Hospital Northern Centre for Cancer Care Freeman Hospital Newcastle Biomedicine Clinical Research Platforms, Royal Victoria Infirmary Mark.verrill@nuth.nhs.uk mary.comiskey@nuth.nhs.uk Paddy.Stevenson@nuth.nhs.uk phyl.whenray@btinternet.com scott.wilkes@newcastle.ac.uk The North of England Cancer Research Network– North operates as part of the NIHR NCRN in England. It is part of the National Institute for Health Research and forms part of the UK Clinical Research Network. The networks support and deliver high quality clinical research studies.NECRN-North Constitution 2012 22 Steve Williamson Consultant Pharmacist North of England Cancer Network Steve.Williamson@necn.nhs.uk Dr Tony Branson Clinical Director/Consultant Clinical Oncologist Clinical Cancer Lead Head and Neck Surgeon Clinical Cancer Lead Consultant Clinical Oncologist Cancer Lead Northern Centre for Cancer Care Freeman Hospital Newcastle upon Tyne tony.branson@nuth.nhs.uk North Cumbria Jonathan.nicoll@ncuh.nhs.uk Northumbria Healthcare Robert.stirling@nhct.nhs.uk Cancer Lead Breast Surgeon Network Quality and Patient Safety Director Cancer Lead Nurse Consultant Cancer Lead Gateshead Kevin.clark@ghnt.nhs.uk North of England Cancer Network Sarah.rushbrooke@necn.nhs.uk Sunderland Melanie.robertson@chsft.nhs.uk South Tyneside Oliver.schulte@stft.nhs.uk Manager Sir Bobby Robson Unit Clinical Trials Assistant Director R&D Consultant Radiology NCCC, Freeman j.a.charlton@newcastle.ac.uk University Hospital North Durham Julie.cox@cddft.nhs.uk Andrew Welch Dr Jonathan Nicoll Dr Robert Stirling Mr Kevin Clark Sarah Rushbrooke Melanie Robertson Oliver Schulte Julie Charlton Julie Cox Andrew.welch@nuth.nhs.uk The North of England Cancer Research Network– North operates as part of the NIHR NCRN in England. It is part of the National Institute for Health Research and forms part of the UK Clinical Research Network. The networks support and deliver high quality clinical research studies.NECRN-North Constitution 2012 23 Appendix 5 Service Level Agreements (10-5A-101) North of England Cancer Research Network North (NECRN-N) Service Level Agreement Parties: North of England Cancer Research Network North (NECRN-N) Dr Anne Lennard, Clinical Lead for Research, North of England Cancer Research Network – North. Newcastle upon Tyne Hospitals NHS Foundation Trust Representatives: Mr Andrew Welch Clinical Lead for Cancer Newcastle upon Tyne Hospitals NHS Foundation Trust David Allison Chief Operating Officer for Newcastle upon Tyne Hospitals NHS Foundation Trust Professor Gary Ford Director R&D for Newcastle upon Tyne Hospitals NHS Foundation Trust Proposed Service Level Agreement: st 1. Period: April 2012 to 31 March 2013 1.1. This Service Level Agreement (the Agreement) describes the responsibilities of the North of England Cancer Research Network–North (the Research Network) and Newcastle upon Tyne Hospitals NHS Foundation Trust (the Trust) with regard to arrangements by which both parties will work in partnership to improve cancer care through increased trial entry. 1.2. Trusts are expected to comply with the relevant requirements set out in this agreement and a copy of this agreement will be provided to each trust for reference. 1.3. The manual of cancer measures clearly outlines that it is a requirement within improving Outcomes Guidance that all patients should be offered the opportunity to participate in clinical trials where available. Compliance with Peer Review Measures means every Multi Disciplinary Team (MDT) is required to have an agreed portfolio of trials which is reviewed regularly and discussed annually at Network Site Specific Group (NSSG) meetings in relation to recruitment and agreed programmes of improvement. Peer Review MDT’s responsibility to report annually to NSSG Network will provide recruitment figures annually in the month of February. 2. Background 2.1. The Research Network is part of the National Cancer Research Network (NCRN), which was formed with the aim of improving patient care through better co-ordination and integration of research and by maintaining and enhancing the quality of research. It has been tasked with widening participation in research and, in more quantitative terms, with achieving 10% overall accrual of cancer patients into cancer clinical trials and 7.5% accrual of cancer patients into Randomised controlled trials (RCTs). 2.2. The Agreement describes arrangements by which both parties will work in partnership to improve cancer care through increased trial entry, and it is assumed that each will work to achieve targets set. Failure to achieve the national target may result in funding being withdrawn and reallocated elsewhere in the Network. In borderline cases, increased numbers of referrals of patients by the Trust into NIHR clinical trials at other trusts in the Network will be taken into consideration. 3. Financial arrangements 3.1. The Research Network will be funded by the Department of Health. Continued funding of staff based at all trusts in the Network is dependent on continued funding of the whole Network, which in turn is dependent upon all research networks across England meeting the national target noted above. 3.2. The Research Network undertakes to provide 2.0 WTE Clinical Trials Officers (CTO’S). The contract of employment (held with South Tyneside PCT: host Organisation of the Network) is to be offered on a fixed term basis up to 31st March 2013. 3.3. The Research Network additionally undertakes to provide funding for • 1.0 WTE Band 7 Team leader for NCRN Trials, • 0.5 WTE Band 6 CTO for Haematology • 0.8 WTE Band 6 Research Nurse for Urology • 0.4 WTE Band 5 Trials Coordinator for Paediatric Oncology • 1.0 WTE Band 4 Data manager for Oncology These contracts of employment are devolved to Newcastle upon Tyne Hospitals NHS Foundation Trust on a fixed term basis up to March 2013. 3.4. The Team Leader will be based within the cancer platform at Newcastle upon Tyne NHS Foundation Trust. This post holder will be the Newcastle Team Lead for the Research Network and will at times be required to work at the Research Network Office. 4. Performance Targets and Outcomes In line with the NIHR High Level Objectives (HLO’s) the key performance indicators for the Research Network are: • Sustaining recruitment – both overall and RCT; • Ensuring studies recruit to target within set timeframes; • Efficient set up of new studies at Trust with set HLO timeframes; • To develop the portfolio of studies. The Network aims to maximise the number of cancer patients recruited to Randomised Controlled trials (RCTs) and seeks to improve its recruitment each year. The aim is to recruit 10% of the estimated network cancer population overall. 7.5% of these will be to to RCTs. For the Research Network this means: The overall target for recruitment of cancer patients into trials is 10%. The estimated number of new referrals with cancer is 9200 patients per annum. Overall accrual of 10% means we need 920 patients per annum. 7.5% recruitment to RCTs = 690 patients per annum. Consequently monthly recruitment targets are 77 patients recruited into cancer clinical trials in total. 58 of these patients should enter RCTs. In addition, workload allowances need to be made for setting up trials, screening, treatment and follow-up. Recruitment figures will be reviewed regularly with reports to NSSG’S, relevant trust groups and the Research Network Steering Group. Remedial actions will be highlighted where there are problems, with the expectation that clinical teams will work to address these. Resources allocated from the Research Network are dependent upon activity and will be redistributed when necessary. 5. North of England Cancer Research Network–North Research Core Management Team Responsibilities 5.1. To agree in writing with the Trust targets for trial entry. To monitor Trust progress and provide feedback on recruitment targets and agree actions to be taken. Formal meetings will be held on a twice-yearly basis to discuss progress on targets set. 5.2. To recommend a network wide portfolio of research trials. In collaboration with Trust clinicians and key stakeholders develop this portfolio to meet local needs. 5.3. To assume all legal employment responsibilities for the Clinical Trials Officers with South Tyneside PCT contracts. 5.4. To provide an induction programme/handbook and professional support for research staff supporting the Cancer Portfolio both in Adult and Paediatric settings. 5.5. To provide line management for the Clinical Trials Officers, liaising closely with the Trust nominated local line manager. 5.6. To support standard policies, operating procedures and generic patient information sheets for local use. 5.7. To provide the trust with information required for peer review in relation to portfolio studies. 5.8. To provide information, support and access to NIHR/NCRN training courses; for staff working on the cancer trials portfolio. 5.9. To provide regular reports to the Research Network Steering Committee and the North of England Cancer Network Board on progress and future strategic development. 5.10. To liaise with adjacent Cancer Research Networks to ensure that there is appropriate integration and support. 5.11. To ensure trials are conducted in accordance with Good Clinical Practice and The DoH Research Governance Framework (www.doh.gov.uk/research). 6. Trust Responsibilities 6.1. To work to achieve NCRN targets set nationally and liaise with the North of England Cancer Research Network- North Manager on the development of locally agreed targets for future monitoring. 6.2. The NCRN Team Leader will provide regular reports to the Research Network core management team and the trust locality Group on progress against targets. 6.3. To ensure that the activities of Clinical Trials Officers are limited to those agreed with the North of England Cancer Research Network- North. 6.4. To ensure the Clinical Trials Officers have a named manager, local induction programme and regular joint appraisal. 6.5. To undertake to work with the Research Network to ensure any line management issues are resolved satisfactorily. 6.6. To provide suitable accommodation and IT support for the Clinical Trials Officers 6.7. The Clinical Trials Officers will be expected to attend regular meetings and training provided by the Network. 6.8. To ensure trials are conducted in accordance with Good Clinical Practice and the DoH Research Governance Framework (www.doh.gov.uk/research). 6.9. To support the process of gaining approval for new trials and, working with trust research staff, to update relevant local committees with data concerning serious adverse events etc. 6.10. The Clinical Trials Officers will ensure that any significant issues affecting NCRN trials or recruitment into those trials are reported to the Research Network and the Trust. 6.11. To help raise awareness amongst all staff of the importance of clinical trials as a means of improving clinical care, and to ensure that clinical trial entry is integrated into core trust business. 6.12. To work with the North of England Cancer Research Network- North and The Northumberland, Tyne and Wear Comprehensive Local Research Network (Service) to enhance and promote research as part of standard patient care. 7. Monitoring and Liaison The Trust will nominate a lead manager for the service provided under this SLA. The contact points for this agreement are: For the Network: For the Trust: North of England Cancer Research Network-North Clinical Lead for Research Research Manager Clinical Lead for Cancer Services and Business Manager for Cancer Services R&D Director 8. Resolution of Disputes Any dispute between the two parties should be resolved by representatives from the Research Network and Trust. Provision of funding is subject to the receipt by the Research Network of a signed copy of this Agreement, and its continuation is contingent upon meeting agreed targets for patient recruitment into NCRN clinical trials. Signed: For and on behalf of the Trust: Name: Mr Andrew Welch Title: Clinical Lead for Cancer Signed: Date: Signed: For and on behalf of the Trust: Name: Mr David Allison Title: Chief Operating Officer Date: Signed: Signed: Signed: For and on behalf of the Trust: Name: Professor Gary Ford Title: Director R&D for Newcastle upon Tyne Hospitals NHS Foundation Trust Date: Signed: For and on behalf of the Research Network: Name: Dr Anne Lennard Title: Clinical Lead North of England Cancer Research Network North Date: North of England Cancer Research Network North (NECRN-N) Service Level Agreement Parties: North of England Cancer Research Network North (NECRN-N) Representative: Dr Anne Lennard, Clinical Lead for Research, North of England Cancer Research Network – North. County Durham & Darlington NHS Foundation Trust Representatives: Mr John Macdonald Clinical Lead for Cancer County Durham & Darlington NHS Foundation Trust Mrs Lorraine Legg Associate Director Corporate Medical Services for County Durham & Darlington NHS Foundation Trust Dr Yan Yiannakou Director R&D County Durham & Darlington NHS Foundation Trust Proposed Service Level Agreement: st 6. Period: April 2012 to 31 March 2013 6.1. This Service Level Agreement (the Agreement) describes the responsibilities of the North of England Cancer Research Network–North (the Research Network) and County Durham & Darlington NHS Foundation Trust (the Trust) with regard to arrangements by which both parties will work in partnership to improve cancer care through increased trial entry. 6.2. Trusts are expected to comply with the relevant requirements set out in this agreement and a copy of this agreement will be provided to each trust for reference. 6.3. The manual of cancer measures clearly outlines that it is a requirement within improving Outcomes Guidance that all patients should be offered the opportunity to participate in clinical trials where available. Compliance with Peer Review Measures means every Multi Disciplinary Team (MDT) is required to have an agreed portfolio of trials which is reviewed regularly and discussed annually at Network Site Specific Group (NSSG) meetings in relation to recruitment and agreed programmes of improvement. Peer Review MDT’s responsibility to report annually to NSSG Network will provide recruitment figures annually in the month of February. 7. Background 7.1. The Research Network is part of the National Institute of Health Research (NIHR), which was formed with the aim of improving patient care through better co-ordination and integration of research and by maintaining and enhancing the quality of research. It has been tasked with widening participation in research and, in more quantitative terms, with achieving 10% overall accrual of cancer patients into cancer clinical trials and 7.5% accrual of cancer patients into Randomised controlled trials (RCTs). 7.2. This agreement describes arrangements by which both parties will work in partnership to improve cancer care through increased trial recruitment, and it is expected that each will work to achieve targets set. Failure to achieve the national target may result in funding being withdrawn and reallocated elsewhere in the Network. In borderline cases, increased numbers of referrals of patients by the Trust into NIHR clinical trials at other trusts in the Network will be taken into consideration. 8. Financial arrangements 8.1. The Research Network will be funded by the Department of Health. Continued funding of staff based at all trusts in the Network is dependent on continued funding of the whole Network, which in turn is dependent upon all research networks across England meeting the national targets noted above. 8.2. The Research Network undertakes to provide funding for a 1.0 WTE Research Nurse (AFC Band 6). The contract of employment is devolved to County Durham and Darlington NHS Foundation Trust on a fixed term basis up to March 2013. 8.3. The Research Network undertakes to provide 0.4 WTE Clinical Trials Assistant (AFC Band 3) to support the Research Nurse. The contract of employment is devolved to County Durham and Darlington NHS Foundation Trust on a fixed term basis up to March 2013. 9. Performance Targets and Outcomes In line with the NIHR High Level Objectives (HLO’s) the key performance indicators for the Research Network are: • Sustaining recruitment – both overall and RCT; • Ensuring studies recruit to target within set timeframes; • Efficient set up of new studies at Trust with set HLO timeframes; • To develop the portfolio of studies. The Network aims to maximise the number of cancer patients recruited to Randomised Controlled trials (RCTs) and seeks to improve its recruitment each year. The aim is to recruit 10% of the estimated network cancer population overall. 7.5% of these will be to to RCTs. For the Research Network this means: The overall target for recruitment of cancer patients into trials is 10%. The estimated number of new referrals with cancer is 9200 patients per annum. Overall accrual of 10% means we need 920 patients per annum. 7.5% recruitment to RCTs = 690 patients per annum. Consequently monthly recruitment targets are 77 patients recruited into cancer clinical trials in total. 58 of these patients should enter RCTs. In addition, workload allowances need to be made for setting up trials, screening, treatment and follow-up. Recruitment figures will be reviewed regularly with reports to NSSG’S, relevant trust groups and the Research Network Steering Group. Remedial actions will be highlighted where there are problems, with the expectation that clinical teams will work to address these. Resources allocated from the Research Network are dependent upon activity and will be redistributed when necessary. 10. North of England Cancer Research Network–North Research Core Management Team Responsibilities 10.1. To agree in writing with the Trust targets for trial entry. To monitor Trust progress and provide feedback on recruitment targets and agree actions to be taken. Formal meetings will be held on a twice-yearly basis to discuss progress on targets set. 10.2. To recommend a network wide portfolio of research trials. In collaboration with Trust clinicians and key stakeholders develop this portfolio to meet local needs. 10.3. To provide an induction programme and continuing professional support for the Research Nurse, Clinical Trials Assistant and Research Staff supporting the cancer portfolio. 10.4. The Network Team Leader Julia Scott will provide support for the staff and work regularly within the Trust. 10.5. The Network Team Leader will work with the Trusts Line Manager in relation to appraisals and performance development for the Research Network funded staff. 10.6. To support standard policies, operating procedures and generic patient information sheets for local use. 10.7. To provide the trust with information required for peer review in relation to portfolio studies. 10.8. To provide information, support and access to NIHR/NCRN training courses for staff working on the cancer trials portfolio. 10.9. To provide regular reports to the Research Network Steering Committee and the North of England Cancer Network Board on progress and future strategic development. 10.10. To liaise with adjacent Cancer Research Networks and clinical research networks to ensure that there is appropriate integration and support. 10.11. To ensure trials are conducted in accordance with Good Clinical Practice and The DoH Research Governance Framework (www.doh.gov.uk/research). 6. Trust Responsibilities 6.1. To work to achieve NCRN targets set nationally and liaise with the North of England Cancer Research Network- North Manager on the development of locally agreed targets for future monitoring. 6.2To undertake to nominate an appropriate representative (and understudy) from the Trust who will attend the Research Network Group Meeting, which meets twice a year. 6.3. The NCRN Team Leader will provide regular reports to the Research Network core management team and the trust locality Group on progress against targets. 6.4. To ensure that the activities of Clinical Trials Officers are limited to those agreed with the North of England Cancer Research Network- North. 6.5. To ensure the Clinical Trials Officers have a named manager, local induction programme and regular joint appraisal. 6.6. To undertake to work with the Research Network to ensure any line management issues are resolved satisfactorily. 6.7. To provide suitable accommodation and IT support for the Clinical Trials Officers 6.8. The Clinical Trials Officers will be expected to attend regular meetings and training provided by the Network. 6.9. To ensure trials are conducted in accordance with Good Clinical Practice and the DoH Research Governance Framework (www.doh.gov.uk/research). 6.10. To support the process of gaining approval for new trials and working with trust research staff to update relevant local committees with data concerning serious adverse events etc. 6.11. The Clinical Trials Officer will ensure that any significant issues affecting NCRN trials or recruitment into those trials are reported to the Research Network and the Trust. 6.12. To help raise awareness amongst all staff of the importance of clinical trials as a means of improving clinical care, and to ensure that clinical trial entry is integrated into core trust business. 6.13. To work with the North of England Cancer Research Network- North and The Northumberland, Tyne and Wear Comprehensive Local Research Network (Service) to enhance and promote research as part of standard patient care. 7. Monitoring and Liaison The Trust will nominate a lead manager for the service provided under this SLA. The contact points for this agreement are: For the Network: For the Trust: North of England Cancer Research Network-North Clinical Lead for Research Research Manager Clinical Lead for Cancer Services and Business Manager for Cancer Services 8. Resolution of Disputes Any dispute between the two parties should be resolved by representatives from the Research Network and theTrust. Provision of funding is subject to the receipt by the Research Network of a signed copy of this Agreement, and its continuation is contingent upon meeting agreed targets for patient recruitment into NCRN clinical trials. Signed: For and on behalf of the Trust: Name: John Macdonald Signed: Title: Clinical Lead for Cancer Date: Signed: Signed: Signed: Signed: For and on behalf of the Trust: Name: Dr Yan Yiannakou Title: Director R&D Date: Signed: For and on behalf of the Trust: Name: Lorraine Legg Title: Associate Director Corporate Medical Services Date: For and on behalf of the Research Network: Name: Dr Anne Lennard Title: Clinical Lead North of England Cancer Research Network North North of England Cancer Research Network North (NECRN-N) Service Level Agreement Parties: North of England Cancer Research Network North (NECRN-N) Representative: Dr Anne Lennard, Clinical Lead for Research, North of England Cancer Research Network – North. North Cumbria University Hospitals NHS Trust Representatives: Dr Jonathon Nicoll Clinical Lead for Cancer North Cumbria University Hospitals NHS Trust Mr Leon Jonker R&D Manager North Cumbria University Hospitals NHS Trust Proposed Service Level Agreement: st 11. Period: April 2012 to 31 March 2013 11.1. This Service Level Agreement (the Agreement) describes the responsibilities of the North of England Cancer Research Network–North (the Research Network) and North Cumbria University Hospitals NHS Trust (the Trust) with regard to arrangements by which both parties will work in partnership to improve cancer care through increased trial entry. 11.2. Trusts are expected to comply with the relevant requirements set out in this agreement and a copy of this agreement will be provided to each trust for reference. 11.3. The manual of cancer measures clearly outlines that it is a requirement within improving Outcomes Guidance that all patients should be offered the opportunity to participate in clinical trials where available. Compliance with Peer Review Measures means every Multi Disciplinary Team (MDT) is required to have an agreed portfolio of trials which is reviewed regularly and discussed annually at Network Site Specific Group (NSSG) meetings in relation to recruitment and agreed programmes of improvement. Peer Review MDT’s responsibility to report annually to NSSG Network will provide recruitment figures annually in the month of February. 12. Background 12.1. The Research Network is part of the National Cancer Research Network (NCRN), which was formed with the aim of improving patient care through better co-ordination and integration of research and by maintaining and enhancing the quality of research. It has been tasked with widening participation in research and, in more quantitative terms, with achieving 10% overall accrual of cancer patients into cancer clinical trials and 7.5% accrual of cancer patients into Randomised controlled trials (RCTs). 12.2. The Agreement describes arrangements by which both parties will work in partnership to improve cancer care through increased trial entry, and it is assumed that each will work to achieve targets set. Failure to achieve the national target may result in funding being withdrawn and reallocated elsewhere in the Network. In borderline cases, increased numbers of referrals of patients by the Trust into NIHR clinical trials at other trusts in the Network will be taken into consideration. 13. Financial arrangements 13.1. The Research Network will be funded by the Department of Health. Continued funding of staff based at all trusts in the Network is dependent on continued funding of the whole Network, which in turn is dependent upon all research networks across England meeting the national targets noted above. 13.2. The Research Network undertakes to provide a 1.0 WTE (AFC Band 7) Senior Clinical Trials Officer (CTO). The contract of employment (held with North Cumbria University Hospitals NHS Trust, host Organisation of the Network) is to be offered on a fixed term basis up to 31 March 2013. The Cancer Research Network will meet training costs. 13.3. The Research Network undertakes to provide 0.2 WTE Clinical Trials Assistant (AFC Band 3) to support the CTO. The contract of employment is devolved to North Cumbria University Hospitals NHS Trust on a fixed term basis up to March 2013. 14. Performance Targets and Outcomes In line with the NIHR High Level Objectives (HLO’s) the key performance indicators for the Research Network are: • Sustaining recruitment – both overall and RCT; • Ensuring studies recruit to target within set timeframes; • Efficient set up of new studies at Trust with set HLO timeframes; • To develop the portfolio of studies. The Network aims to maximise the number of cancer patients recruited to Randomised Controlled trials (RCTs) and seeks to improve its recruitment each year. The aim is to recruit 10% of the estimated network cancer population overall. 7.5% of these will be to RCTs. For the Research Network this means: The overall target for recruitment of cancer patients into trials is 10%. The estimated number of new referrals with cancer is 9200 patients per annum. Overall accrual of 10% means we need 920 patients per annum. 7.5% recruitment to RCTs = 690 patients per annum. Consequently monthly recruitment targets are 77 patients recruited into cancer clinical trials in total. 58 of these patients should enter RCTs. In addition, workload allowances need to be made for setting up trials, screening, treatment and follow-up. Recruitment figures will be reviewed regularly with reports to NSSG’S, relevant trust groups and the Research Network Steering Group. Remedial actions will be highlighted where there are problems, with the expectation that clinical teams will work to address these. Resources allocated from the Research Network are dependent upon activity and will be redistributed when necessary. 15. North of England Cancer Research Network–North Research Core Management Team Responsibilities 15.1. To agree in writing with the Trust targets for trial entry. To monitor Trust progress and provide feedback on recruitment targets and agree actions to be taken. Formal meetings will be held on a twice-yearly basis to discuss progress on targets set. 15.2. To recommend a network wide portfolio of research trials. In collaboration with Trust clinicians and key stakeholders to develop this portfolio to meet local needs. 15.3. To provide an induction programme and continuing professional support for the Clinical Trails Officer, Clinical Trials Assistant and Cancer Research Staff supporting the portfolio . 15.4. To provide line management for the Clinical Trails Officer, liaising closely with the Trust nominated local line manager. 15.5. To support standard policies, operating procedures and generic patient information sheets for local use. 15.6. To provide the trust with information required for peer review in relation to portfolio studies. 15.7. To provide information, support and access to NIHR/NCRN training courses for staff working on the cancer trials portfolio. 15.8. To provide regular reports to the Research Network Steering Committee and the North of England Cancer Network Board on progress and future strategic development. 15.9. To ensure trials are conducted in accordance with Good Clinical Practice and The DoH Research Governance Framework (www.doh.gov.uk/research). 6. Trust Responsibilities 6.1. To work to achieve NIHR/NCRN targets set nationally and liaise with the Research Network Manager on the development of locally agreed targets for trial recruitment. 6.2. To undertake to nominate an appropriate representative (and understudy) from the Trust who will attend the Research Network Group Meeting, which meets twice a year. 6.3. To ensure that the activities of the Research Network funded research staff are limited to those agreed with the Research Network. 6.4. To undertake to work with the Research Network to ensure any line management issues are resolved satisfactorily. 6.5. To provide suitable accommodation and IT support for the Research Network funded research staff. 6.6. The Research Network funded research staff will be expected to attend regular meetings and training provided by the Network. 6.7. To ensure trials are conducted in accordance with Good Clinical Practice and the DoH Research Governance Framework (www.doh.gov.uk/research). 6.8. To support the process of gaining approval for new trials with timeframes linked to the NIHR High Level Objectives. 6.9. To work with trust research staff to update relevant local committees with data concerning serious adverse events etc. 6.10. The R&D department will ensure that any significant issues affecting NCRN trials or recruitment into those trials are reported to the Research Network and the Trust. 6.11. To help raise awareness amongst all staff of the importance of clinical trials as a means of improving clinical care, and to ensure that clinical trial entry is integrated into core trust business. 6.12. To work with the Research Network and the Cumbria and Lancashire Comprehensive Network and the North of England Cancer Network (Service) to enhance and promote research as part of standard patient care. 7. Monitoring and Liaison The Trust will nominate a lead manager for the service provided under this SLA. The contact points for this agreement are: For the Network: For the Trust: North of England Cancer Research Network-North Clinical Lead for Research Research Manager Clinical Lead for Cancer Services and R&D Manager 8. Resolution of Disputes Any dispute between the two parties should be resolved by representatives from the Research Network and Trust. Provision of funding is subject to the receipt by the Research Network of a signed copy of this Agreement, and its continuation is contingent upon meeting agreed targets for patient recruitment into NCRN clinical trials. Signed: For and on behalf of the Trust: Name: Dr Jonathan Nicoll Title: Clinical Lead for Cancer Signed: Date: Signed: For and on behalf of the Trust: Name: Mr Leon Jonker Title: Research Manager Date: Signed: Name: Dr Anne Lennard Title: Clinical Lead North of England Cancer Research Network North Date: North of England Cancer Research Network North (NECRN-N) Service Level Agreement Parties: North of England Cancer Research Network North (NECRN-N) Representative: Dr Anne Lennard, Clinical Lead for Research, North of England Cancer Research Network – North. Northumbria Healthcare NHS Foundation Trust Representatives: Dr Bob Stirling Clinical Lead for Cancer Northumbria Healthcare NHS Foundation Trust Mrs Rosemary Stephenson Director of Nursing and Cancer Services Northumbria Healthcare NHS Foundation Trust Mrs Caroline Potts Research and Development Manager Northumbria Healthcare NHS Foundation Trust Proposed Service Level Agreement: st 16. Period: April 2012 to 31 March 2013 16.1. This Service Level Agreement (the Agreement) describes the responsibilities of the North of England Cancer Research Network–North (the Research Network) and Northumbria Healthcare NHS Foundation Trust (the Trust) with regard to arrangements by which both parties will work in partnership to improve cancer care through increased trial entry. 16.2. Trusts are expected to comply with the relevant requirements set out in this agreement and a copy of this agreement will be provided to each trust for reference. 16.3. The manual of cancer measures clearly outlines that it is a requirement within improving Outcomes Guidance that all patients should be offered the opportunity to participate in clinical trials where available. Compliance with Peer Review Measures means every Multi Disciplinary Team (MDT) is required to have an agreed portfolio of trials which is reviewed regularly and discussed annually at Network Site Specific Group (NSSG) meetings in relation to recruitment and agreed programmes of improvement. Peer Review MDT’s responsibility to report annually to NSSG Network will provide recruitment figures annually in the month of February. 17. Background 17.1. The Research Network is part of the National Cancer Research Network (NCRN), which was formed with the aim of improving patient care through better co-ordination and integration of research and by maintaining and enhancing the quality of research. It has been tasked with widening participation in research and, in more quantitative terms, with achieving 10% overall accrual of cancer patients into cancer clinical trials and 7.5% accrual of cancer patients into Randomised controlled trials (RCTs). 17.2. The Agreement describes arrangements by which both parties will work in partnership to improve cancer care through increased trial entry, and it is assumed that each will work to achieve targets set. Failure to achieve the national target may result in funding being withdrawn and reallocated elsewhere in the Network. In borderline cases, increased numbers of referrals of patients by the Trust into NIHR clinical trials at other trusts in the Network will be taken into consideration. 18. Financial arrangements 18.1. The Research Network will be funded by the Department of Health. Continued funding of staff based at all trusts in the Network is dependent on continued funding of the whole Network, which in turn is dependent upon all research networks across England meeting the national targets noted above. 18.2. The Research Network undertakes to provide 2.0 WTE Clinical Trials Officers (CTO’s) (AFC Band 6) and one 0.4 WTE Clinical Trials Assistant (AFC Band 3) to support the CTO’s The contracts of employment (held with South Tyneside PCT: host Organisation of the Network) are to be offered on a fixed term basis up to 31 March 2013. The Cancer Research Network will meet training costs. If a vacancy arises this will be reviewed in discussion with the Trust. 19. Performance Targets and Outcomes In line with the NIHR High Level Objectives (HLO’s) the key performance indicators for the Research Network are: • Sustaining recruitment – both overall and RCT; • Ensuring studies recruit to target within set timeframes; • Efficient set up of new studies at Trust with set HLO timeframes; • To develop the portfolio of studies. The Network aims to maximise the number of cancer patients recruited to Randomised Controlled trials (RCTs) and seeks to improve its recruitment each year. The aim is to recruit 10% of the estimated network cancer population overall. 7.5% of these will be to to RCTs. For the Research Network this means: The overall target for recruitment of cancer patients into trials is 10%. The estimated number of new referrals with cancer is 9200 patients per annum. Overall accrual of 10% means we need 920 patients per annum. 7.5% recruitment to RCTs = 690 patients per annum. Consequently monthly recruitment targets are 77 patients recruited into cancer clinical trials in total. 58 of these patients should enter RCTs. In addition, workload allowances need to be made for setting up trials, screening, treatment and follow-up. Recruitment figures will be reviewed regularly with reports to NSSG’S, relevant trust groups and the Research Network Steering Group. Remedial actions will be highlighted where there are problems, with the expectation that clinical teams will work to address these. Resources allocated from the Research Network are dependent upon activity and will be redistributed when necessary. 20. North of England Cancer Research Network–North Research Core Management Team Responsibilities 20.1. To agree in writing with the Trust targets for trial entry. To monitor Trust progress and provide feedback on recruitment targets and agree actions to be taken. Formal meetings will be held on a twice-yearly basis to discuss progress on targets set. 20.2. To recommend a network wide portfolio of research trials. In collaboration with Trust clinicians and key stakeholders develop this portfolio to meet local needs. 20.3. To assume all legal employment responsibilities for the Clinical Trials Officers and Trials Assistant. 20.4. To provide an induction programme and continuing professional support for the Clinical Trials Officers, Clinical Trials Assistant and Research Staff supporting the cancer portfolio. 20.5. The Network Team Leader Julia Scott will provide support for the staff and work regularly within the Trust. 20.6. To provide line management for the Clinical Trails Officers and Clinical Trials Assistant liaising closely with the Trust nominated local line manager. 20.7. To support standard policies, operating procedures and generic patient information sheets for local use. 20.8. To provide the trust with information required for peer review in relation to portfolio studies. 20.9. To provide information, support and access to NIHR/NCRN training courses for staff working on the cancer trials portfolio. 20.10. To provide regular reports to the Research Network Steering Committee and the North of England Cancer Network Board on progress and future strategic development. 20.11. To ensure trials are conducted in accordance with Good Clinical Practice and The DoH Research Governance Framework (www.doh.gov.uk/research). 6. Trust Responsibilities 6.1. To work to achieve NIHR/NCRN targets set nationally and liaise with the Research Network Manager on the development of locally agreed targets for trial recruitment. 6.2. To undertake to nominate an appropriate representative (and understudy) from the Trust who will attend the Research Network Group Meeting, which meets twice a year. 6.3. To ensure that the activities of Clinical Trials Officers and the Trials Assistant are limited to those agreed with the North of England Cancer Research Network- North. 6.4. To ensure the Clinical Trials Officers and Trials Assistant have a named Trust Line manager, local induction programme and joint appraisal. 6.5. To undertake to work with the Research Network to ensure any line management issues are resolved satisfactorily. 6.6. To provide suitable accommodation and IT support for the Clinical Trials Officers and Trials Assistant. 6.7. The Clinical Trials Officers and Trials Assistant will be expected to attend regular meetings and training provided by the Network. 6.8. To ensure trials are conducted in accordance with Good Clinical Practice and the DoH Research Governance Framework (www.doh.gov.uk/research). 6.9. To support the process of gaining approval for new trials within time frames linked to the NIHR High Level Objectives. 6.10. To work with trust research staff to update relevant local committees with data concerning serious adverse events etc. 6.11. The R&D department will ensure that any significant issues affecting NCRN trials or recruitment into those trials are reported to the Research Network and the Trust. 6.12. To help raise awareness amongst all staff of the importance of clinical trials as a means of improving clinical care, and to ensure that clinical trial entry is integrated into core trust business. 6.13. To work with the Research Network and the Northumberland Tyne and Wear Comprehensive Network and the North of England Cancer Network (Service) to enhance and promote research as part of standard patient care. 7. Monitoring and Liaison The Trust will nominate a lead manager for the service provided under this SLA. The contact points for this agreement are: For the Network: For the Trust: North of England Cancer Research Network-North Clinical Lead for Research Research Manager Clinical Lead for Cancer Services and Business Manager for Cancer Services Manager Research and Development 8. Resolution of Disputes Any dispute between the two parties should be resolved by representatives from the Research Network and Trust. Provision of funding is subject to the receipt by the Research Network of a signed copy of this Agreement, and its continuation is contingent upon meeting agreed targets for patient recruitment into NCRN clinical trials. Signed: Signed: For and on behalf of the Trust: Name: Dr Stirling Title: Clinical Lead for Cancer Signed: Date: For and on behalf of the Trust: Name: Mrs Caroline Potts For and on behalf of the Trust: Name: Caroline Potts Title: Manager R&D Date: Signed: For and on behalf of the Trust: Name: Mrs Rosemary Stephenson Title: Director of Nursing and Cancer Services Date: For and on behalf of the Research Network: Name: Dr Anne Lennard Title: Clinical Lead North of England Cancer Research Network North Date: North of England Cancer Research Network North (NECRN-N) Service Level Agreement Parties: North of England Cancer Research Network North (NECRN-N) Representative: Dr Anne Lennard, Clinical Lead for Research, North of England Cancer Research Network – North. Gateshead Health NHS Foundation Trust Representatives: Mr Keith Godfrey, Medical Director / Lead Clinician for Gynaecological Oncology Gateshead Health NHS Foundation Trust Mr Alan Thomas, Director of R & D Gateshead Health NHS Foundation Trust Proposed Service Level Agreement: st 21. Period: April 2012 to 31 March 2013 21.1. This Service Level Agreement (the Agreement) describes the responsibilities of the North of England Cancer Research Network–North (the Research Network) and Gateshead health NHS Foundation Trust (the Trust) with regard to arrangements by which both parties will work in partnership to improve cancer care through increased trial entry. 21.2. Trusts are expected to comply with the relevant requirements set out in this agreement and a copy of this agreement will be provided to each trust for reference. 21.3. The manual of cancer measures clearly outlines that it is a requirement within improving Outcomes Guidance that all patients should be offered the opportunity to participate in clinical trials where available. Compliance with Peer Review Measures means every Multi Disciplinary Team (MDT) is required to have an agreed portfolio of trials which is reviewed regularly and discussed annually at Network Site Specific Group (NSSG) meetings in relation to recruitment and agreed programmes of improvement. Peer Review MDT’s responsibility to report annually to NSSG Network will provide recruitment figures annually in the month of February. 22. Background 22.1. The Research Network is part of the National Cancer Research Network (NCRN), which was formed with the aim of improving patient care through better co-ordination and integration of research and by maintaining and enhancing the quality of research. It has been tasked with widening participation in research and, in more quantitative terms, with achieving 10% overall accrual of cancer patients into cancer clinical trials and 7.5% accrual of cancer patients into Randomised controlled trials (RCTs). 22.2. The Agreement describes arrangements by which both parties will work in partnership to improve cancer care through increased trial entry, and it is assumed that each will work to achieve targets set. Failure to achieve the national target may result in funding being withdrawn and reallocated elsewhere in the Network. In borderline cases, increased numbers of referrals of patients by the Trust into NIHR clinical trials at other trusts in the Network will be taken into consideration. 22.3. Compliance with Peer Review Measures for Network Tumour Groups and MDT’s requires recruitment into an agreed local portfolio of NCRN approved studies. 23. Financial arrangements 23.1. The Research Network will be funded by the Department of Health. Continued funding of staff based at all trusts in the Network is dependent on continued funding of the whole Network, which in turn is dependent upon all research networks across England meeting the national target noted above. 23.2. The Research Network undertakes to provide a 0.8 WTE Clinical Trials Officer (CTO). The contract of employment (held with South Tyneside PCT host Organisation of the Network) is to be offered on a fixed term basis up to 31st March 2013. The Cancer Research Network will meet training costs. 23.3. The Research Network Team Leader and the two CTO’s working at other South of Tyne NHS Foundation Trusts will require letters of access to provide cross cover as needed. 24. Performance Targets and Outcomes In line with the NIHR High Level Objectives (HLO’s) the key performance indicators for the Research Network are: • Sustaining recruitment – both overall and RCT; • Ensuring studies recruit to target within set timeframes; • Efficient set up of new studies at Trust with set HLO timeframes; • To develop the portfolio of studies. The Network aims to maximise the number of cancer patients recruited to Randomised Controlled trials (RCTs) and seeks to improve its recruitment each year. The aim is to recruit 10% of the estimated network cancer population overall. 7.5% of these will be to RCTs. For the Research Network this means: The overall target for recruitment of cancer patients into trials is 10%. The estimated number of new referrals with cancer is 9200 patients per annum. Overall accrual of 10% means we need 920 patients per annum. 7.5% recruitment to RCTs = 690 patients per annum. Consequently monthly recruitment targets are 77 patients recruited into cancer clinical trials in total. 58 of these patients should enter RCTs. In addition, workload allowances need to be made for setting up trials, screening, treatment and follow-up. Recruitment figures will be reviewed regularly with reports to NSSG’S, relevant trust groups and the Research Network Steering Group. Remedial actions will be highlighted where there are problems, with the expectation that clinical teams will work to address these. Resources allocated from the Research Network are dependent upon activity and will be redistributed when necessary. 25. North of England Cancer Research Network–North Research Core Management Team Responsibilities 25.1. To agree in writing with the Trust targets for trial entry. To monitor Trust progress and provide feedback on recruitment targets and agree actions to be taken. Formal meetings will be held on a twice-yearly basis to discuss progress on targets set. 25.2. To recommend a network wide portfolio of research trials. In collaboration with Trust clinicians and key stakeholders develop this portfolio to meet local needs. 25.3. To assume all legal employment responsibilities for the Clinical Trials Officer. 25.4. To provide an induction programme and continuing professional support for the Clinical Trials Officer and Research Staff supporting the cancer portfolio. 25.5. The Network Team Leader Julia Scott will provide support for the staff and work regularly within the Trust. 25.6. To provide line management for the Clinical Trials Officer liaising closely with the Trust nominated local line manager. 25.7. To support standard policies, operating procedures and generic patient information sheets for local use. 25.8. To provide the trust with information required for peer review in relation to portfolio studies. 25.9. To provide information, support and access to NIHR/NCRN training courses; for staff working on the cancer trials portfolio. 25.10. To provide regular reports to the Research Network Steering Committee and the North of England Cancer Network Board on progress and future strategic development. 25.11. To ensure trials are conducted in accordance with Good Clinical Practice and The DoH Research Governance Framework (www.doh.gov.uk/research). 6. Trust Responsibilities 6.1. To work to achieve NIHR/NCRN targets set nationally and liaise with the Research Network Manager on the development of locally agreed targets for trial recruitment. 6.2. To undertake to nominate an appropriate representative (and understudy) from the Trust who will attend the Research Network Group Meeting, which meets twice a year. 6.3. To ensure that the activities of Clinical Trials Officer are limited to those agreed with the North of England Cancer Research Network- North. 6.4. To ensure the Clinical Trials Office has a named Trust Line manager, local induction programme and regular joint appraisal. 6.5. To undertake to work with the Research Network to ensure any line management issues are resolved satisfactorily. 6.6. To provide suitable accommodation and IT support for the Clinical Trials Officer. 6.7. The Clinical Trials Officer will be expected to attend regular meetings and training provided by the Network. 6.8. To ensure trials are conducted in accordance with Good Clinical Practice and the DoH Research Governance Framework (www.doh.gov.uk/research). 6.9. To support the process of gaining approval for new trials within the timeframes of the NIHR High Level Objectives. 6.10. To work with trust research staff to update relevant local committees with data concerning serious adverse events etc. 6.11. The R&D department will ensure that any significant issues affecting NCRN trials or recruitment into those trials are reported to the Research Network and the Trust. 6.12. To help raise awareness amongst all staff of the importance of clinical trials as a means of improving clinical care, and to ensure that clinical trial entry is integrated into core trust business. 6.13. To work with the Research Network and the Northumberland Tyne and Wear Comprehensive Network and the North of England Cancer Network (Service) to enhance and promote research as part of standard patient care. 7. Monitoring and Liaison The Trust will nominate a lead manager for the service provided under this SLA. The contact points for this agreement are: For the Network: For the Trust: North of England Cancer Research Network-North Clinical Lead for Research Research Manager Business Manager for Cancer Services and R&D manager 8. Resolution of Disputes Any dispute between the two parties should be resolved by representatives from the Research Network and Trust. Provision of funding is subject to the receipt by the Research Network of a signed copy of this Agreement, and its continuation is contingent upon meeting agreed targets for patient recruitment into NCRN clinical trials. Signed: Signed: For and on behalf of the Trust: Name: Mr Keith Godfrey Title: Signed: For and on behalf of the Trust: Name: Dr Alan Thomas Title: Signed: Date: Date: For and on behalf of the Research Network: Name: Dr Anne Lennard Title: Clinical Lead North of England Cancer Research Network North Date: North of England Cancer Research Network North (NECRN-N) Service Level Agreement Parties: North of England Cancer Research Network North (NECRN-N) Representative: Dr Anne Lennard, Clinical Lead for Research, North of England Cancer Research Network – North. South Tyneside Hospitals NHS Foundation Trust Representatives: Helen Ray, Director Clinical Services and Trust Executive Cancer Lead Mrs Elaine Kilgannon, Cancer Manager for South Tyneside Hospitals NHS Foundation Trust. Bev Atkinson, Director Nursing and Trust Executive Lead Research Proposed Service Level Agreement: st 26. Period: April 2012 to 31 March 2013 26.1. This Service Level Agreement (the Agreement) describes the responsibilities of the North of England Cancer Research Network–North (the Research Network) and South Tyneside Hospitals NHS Foundation Trust (the Trust) with regard to arrangements by which both parties will work in partnership to improve cancer care through increased trial entry. 26.2. Trusts are expected to comply with the relevant requirements set out in this agreement and a copy of this agreement will be provided to each trust for reference. 26.3. The manual of cancer measures clearly outlines that it is a requirement within improving Outcomes Guidance that all patients should be offered the opportunity to participate in clinical trials where available. Compliance with Peer Review Measures means every Multi Disciplinary Team (MDT) is required to have an agreed portfolio of trials which is reviewed regularly and discussed annually at Network Site Specific Group (NSSG) meetings in relation to recruitment and agreed programmes of improvement. Peer Review MDT’s responsibility to report annually to NSSG Network will provide recruitment figures annually in the month of February. 27. Background 27.1. The Research Network is part of the National Institute of Health Research (NIHR), which was formed with the aim of improving patient care through better co-ordination and integration of research and by maintaining and enhancing the quality of research. It has been tasked with widening participation in research and, in more quantitative terms, with achieving 10% overall accrual of cancer patients into cancer clinical trials and 7.5% accrual of cancer patients into Randomised controlled trials (RCTs). 27.2. This agreement describes arrangements by which both parties will work in partnership to improve cancer care through increased trial recruitment, and it is expected that each will work to achieve targets set. Failure to achieve the national target may result in funding being withdrawn and reallocated elsewhere in the Network. In borderline cases, increased numbers of referrals of patients by the Trust into NCRN clinical trials at other trusts in the Network will be taken into consideration. 28. Financial arrangements 28.1. The Research Network will be funded by the Department of Health. Continued funding of staff based at all trusts in the Network is dependent on continued funding of the whole Network, which in turn is dependent upon all research networks across England meeting the national target noted above. 28.2. The Research Network undertakes to provide a 1.0 WTE Clinical Trials Officer (CTO). The contract of employment (held with South Tyneside PCT: host Organisation of the Research Network) is to be offered on a fixed term basis up to 31st March 2013. The Research Network will meet training costs. The CTO will be based at the Trust but will also provide cover at another Trust one day a week. 28.3. The Research Network Team Leader and the two CTO’s working at other South of Tyne NHS Foundation Trusts will require letters of access to provide cross cover as needed. 29. Performance Targets and Outcomes In line with the NIHR High Level Objectives (HLO’s) the key performance indicators for the Research Network are: • Sustaining recruitment – both overall and RCT; • Ensuring studies recruit to target within set timeframes; • Efficient set up of new studies at Trust with set HLO timeframes; • To develop the portfolio of studies. The Network aims to maximise the number of cancer patients recruited to Randomised Controlled trials (RCTs) and seeks to improve its recruitment each year. The aim is to recruit 10% of the estimated network cancer population overall. 7.5% of these will be to to RCTs. For the Research Network this means: The overall target for recruitment of cancer patients into trials is 10%. The estimated number of new referrals with cancer is 9200 patients per annum. Overall accrual of 10% means we need 920 patients per annum. 7.5% recruitment to RCTs = 690 patients per annum. Consequently monthly recruitment targets are 77 patients recruited into cancer clinical trials in total. 58 of these patients should enter RCTs. In addition, workload allowances need to be made for setting up trials, screening, treatment and follow-up. Recruitment figures will be reviewed regularly with reports to NSSG’S, relevant trust groups and the Research Network Steering Group. Remedial actions will be highlighted where there are problems, with the expectation that clinical teams will work to address these. Resources allocated from the Research Network are dependent upon activity and will be redistributed when necessary. 30. North of England Cancer Research Network–North Research Core Management Team Responsibilities 30.1. To agree in writing with the Trust targets for trial entry. To monitor Trust progress and provide feedback on recruitment targets and agree actions to be taken. Formal meetings will be held on a twice-yearly basis to discuss progress on targets set. 30.2. To recommend a network wide portfolio of research trials. In collaboration with Trust clinicians and key stakeholders develop this portfolio to meet local needs. 30.3. To assume all legal employment responsibilities for the Clinical Trials Officer. 30.4. To provide an induction programme and continuing professional support for the Clinical Trials Officer and Research Staff supporting the cancer portfolio. 30.5. The Network Team Leader Julia Scott will provide support for the staff and work regularly within the Trust. 30.6. To provide line management for the Clinical Trials Officer liaising closely with the Trust nominated local line manager. 30.7. To support standard policies, operating procedures and generic patient information sheets for local use. 30.8. To provide the trust with information required for peer review in relation to portfolio studies. 30.9. To provide information, support and access to NIHR/NCRN training courses; for staff working on the cancer trials portfolio. 30.10. To provide regular reports to the Research Network Steering Committee and the North of England Cancer Network Board on progress and future strategic development. 30.11. To liaise with adjacent Cancer Research Networks to ensure that there is appropriate integration and support. 30.12. To ensure trials are conducted in accordance with Good Clinical Practice and The DoH Research Governance Framework (www.doh.gov.uk/research). 6. Trust Responsibilities 6.1. To work to achieve NIHR/NCRN targets set nationally and liaise with the Research Network Manager on the development of locally agreed targets for trial recruitment. 6.2. To undertake to nominate an appropriate representative (and understudy) from the Trust who will attend the Research Network Group Meeting, which meets twice a year. 6.3. To ensure that the activities of Clinical Trials Officer are limited to those agreed with the North of England Cancer Research Network- North. 6.4. To ensure the Clinical Trials Officer has a named Trust Line manager, local induction programme and regular joint appraisal. 6.5. To undertake to work with the Research Network to ensure any line management issues are resolved satisfactorily. 6.6. To provide suitable accommodation and IT support for the Clinical Trials Officer. 6.7. The Clinical Trials Officer will be expected to attend regular meetings and training provided by the Network. 6.8. To ensure trials are conducted in accordance with Good Clinical Practice and the DoH Research Governance Framework (www.doh.gov.uk/research). 6.9. To support the process of gaining approval for new trials within the timeframes of the NIHR High Level Objectives. 6.10. To work with trust research staff to update relevant local committees with data concerning serious adverse events etc. 6.11. The R&D department will ensure that any significant issues affecting NCRN trials or recruitment into those trials are reported to the Research Network and the Trust. 6.12. To help raise awareness amongst all staff of the importance of clinical trials as a means of improving clinical care, and to ensure that clinical trial entry is integrated into core trust business. 6.13. To work with the Research Network and the Northumberland Tyne and Wear Comprehensive Network and the North of England Cancer Network (Service) to enhance and promote research as part of standard patient care. 7. Monitoring and Liaison The Trust will nominate a lead manager for the service provided under this SLA. The contact points for this agreement are: For the Network: For the Trust: North of England Cancer Research Network-North Clinical Lead for Research Research Manager Clinical Lead for Cancer Services and Business Manager for Cancer Services 8. Resolution of Disputes Any dispute between the two parties should be resolved by representatives from the Research Network and Trust. Provision of funding is subject to the receipt by the Research Network of a signed copy of this Agreement, and its continuation is contingent upon meeting agreed targets for patient recruitment into NCRN clinical trials. Signed: For and on behalf of the Trust: Name: Helen Ray Title: Director Clinical Services and Trust Executive Signed: Cancer Lead Date: Signed: For and on behalf of the Trust: Name: Elaine Kilgannon Title: Cancer Manager Date: Signed: Signed: Signed: For and on behalf of the Trust: Name: Bev Atkinson Title: Director Nursing and Trust Executive Lead Research Date: Signed: For and on behalf of the Research Network: Name: Dr Anne Lennard Title: Clinical Lead North of England Cancer Research Network North (NECRN-N) Date: North of England Cancer Research Network North (NECRN-N) Service Level Agreement Parties: North of England Cancer Research Network North (NECRN-N) Representative: Dr Anne Lennard, Clinical Lead for Research, North of England Cancer Research Network – North. Sunderland NHS Foundation Trust Representatives: Mrs Melanie Robertson Clinical Lead for Cancer City Hospitals Sunderland NHS Foundation Trust Mr Kim Hinshaw R&D Director City Hospitals Sunderland NHS Foundation Trust Denise Inskip Cancer Services Manager for City Hospitals Sunderland NHS Foundation Trust Proposed Service Level Agreement: st 31. Period: April 2012 to 31 March 2013 31.1. This Service Level Agreement (the Agreement) describes the responsibilities of the North of England Cancer Research Network–North (the Research Network) and Sunderland NHS Foundation Trust (the Trust) with regard to arrangements by which both parties will work in partnership to improve cancer care through increased trial entry. 31.2. Trusts are expected to comply with the relevant requirements set out in this agreement and a copy of this agreement will be provided to each trust for reference. 31.3. The manual of cancer measures clearly outlines that it is a requirement within improving Outcomes Guidance that all patients should be offered the opportunity to participate in clinical trials where available. Compliance with Peer Review Measures means every Multi Disciplinary Team (MDT) is required to have an agreed portfolio of trials which is reviewed regularly and discussed annually at Network Site Specific Group (NSSG) meetings in relation to recruitment and agreed programmes of improvement. Peer Review MDT’s responsibility to report annually to NSSG Network will provide recruitment figures annually in the month of February. 32. Background 32.1. The Research Network is part of the National Cancer Research Network (NCRN), which was formed with the aim of improving patient care through better co-ordination and integration of research and by maintaining and enhancing the quality of research. It has been tasked with widening participation in research and, in more quantitative terms, with achieving 10% overall accrual of cancer patients into cancer clinical trials and 7.5% accrual of cancer patients into Randomised controlled trials (RCTs). 32.2. The Agreement describes arrangements by which both parties will work in partnership to improve cancer care through increased trial entry, and it is assumed that each will work to achieve targets set. Failure to achieve the national target may result in funding being withdrawn and reallocated elsewhere in the Network. In borderline cases, increased numbers of referrals of patients by the Trust into NCRN clinical trials at other trusts in the Network will be taken into consideration. 33. Financial arrangements 33.1. The Research Network will be funded by the Department of Health. Continued funding of staff based at all trusts in the Network is dependent on continued funding of the whole Network, which in turn is dependent upon all research networks across England meeting the national targets noted above. 33.2. The Research Network undertakes to provide a 1.0 WTE Clinical Trials Officer (CTO). The contract of employment (held with South Tyneside PCT: host Organisation of the Network) is to be offered on a fixed term basis up to 31st March 2013. The Cancer Research Network will meet training costs. 33.3. The Research Network undertakes to provide 0.6 WTE Research Data Manager (AFC Band 4) to support the Oncology and Haematology teams. The contract of employment is devolved to City Hospitals Sunderland NHS Foundation Trust on a fixed term basis up to 31st March 2013. 33.4. The Research Network Team Leader and the two CTO’s working at other South of Tyne NHS Foundation Trusts will require letters of access to provide cross cover as needed. 34. Performance Targets and Outcomes In line with the NIHR High Level Objectives (HLO’s) the key performance indicators for the Research Network are: • Sustaining recruitment – both overall and RCT; • Ensuring studies recruit to target within set timeframes; • Efficient set up of new studies at Trust with set HLO timeframes; • To develop the portfolio of studies. The Network aims to maximise the number of cancer patients recruited to Randomised Controlled trials (RCTs) and seeks to improve its recruitment each year. The aim is to recruit 10% of the estimated network cancer population overall. 7.5% of these will be to RCTs. For the Research Network this means: The overall target for recruitment of cancer patients into trials is 10%. The estimated number of new referrals with cancer is 9200 patients per annum. Overall accrual of 10% means we need 920 patients per annum. 7.5% recruitment to RCTs = 690 patients per annum. Consequently monthly recruitment targets are 77 patients recruited into cancer clinical trials in total. 58 of these patients should enter RCTs. In addition, workload allowances need to be made for setting up trials, screening, treatment and follow-up. Recruitment figures will be reviewed regularly with reports to NSSG’S, relevant trust groups and the Research Network Steering Group. Remedial actions will be highlighted where there are problems, with the expectation that clinical teams will work to address these. Resources allocated from the Research Network are dependent upon activity and will be redistributed when necessary. 35. North of England Cancer Research Network–North Research Core Management Team Responsibilities 35.1. To agree in writing with the Trust targets for trial entry. To monitor Trust progress and provide feedback on recruitment targets and agree actions to be taken. Formal meetings will be held on a twice-yearly basis to discuss progress on targets set. 35.2. To recommend a network wide portfolio of research trials. In collaboration with Trust clinicians and key stakeholders develop this portfolio to meet local needs. 35.3. To assume all legal employment responsibilities for the Clinical Trials Officer. 35.4. To provide an induction programme and continuing professional support for the Clinical Trials Officers and Research Staff supporting the cancer portfolio. 35.5. The Network Team Leader Julia Scott will provide support for the staff and work regularly within the Trust. 35.6. To provide line management for the Clinical Trials Officer liaising closely with the Trust nominated local line manager. 35.7. To support standard policies, operating procedures and generic patient information sheets for local use. 35.8. To provide the trust with information required for peer review in relation to portfolio studies. 35.9. To provide information, support and access to NIHR/NCRN training courses; for staff working on the cancer trials portfolio. 35.10. To provide regular reports to the Research Network Steering Committee and the North of England Cancer Network Board on progress and future strategic development. 35.11. To liaise with adjacent Cancer Research Networks to ensure that there is appropriate integration and support. 35.12. To ensure trials are conducted in accordance with Good Clinical Practice and The DoH Research Governance Framework (www.doh.gov.uk/research). 6. Trust Responsibilities 6.1. To work to achieve NIHR/NCRN targets set nationally and liaise with the Research Network Manager on the development of locally agreed targets for trial recruitment. 6.2. To undertake to nominate an appropriate representative (and understudy) from the Trust who will attend the Research Network Group Meeting, which meets twice a year. 6.3. To ensure that the activities of Clinical Trials Officers are limited to those agreed with the North of England Cancer Research Network- North. 6.4. To ensure the Clinical Trials Officer has a named Trust Line manager, local induction programme and regular joint appraisal. 6.5. To undertake to work with the Research Network to ensure any line management issues are resolved satisfactorily. 6.6. To provide suitable accommodation and IT support for the Clinical Trials Officers and Data Manager. 6.7. The Clinical Trials Officers will be expected to attend regular meetings and training provided by the Network. 6.8. To ensure trials are conducted in accordance with Good Clinical Practice and the DoH Research Governance Framework (www.doh.gov.uk/research). 6.9. To support the process of gaining approval for new trials within the timeframes of the NIHR High Level Objectives. 6.10. To work with trust research staff to update relevant local committees with data concerning serious adverse events etc. 6.11. The R&D department will ensure that any significant issues affecting NCRN trials or recruitment into those trials are reported to the Research Network and the Trust. 6.12. To help raise awareness amongst all staff of the importance of clinical trials as a means of improving clinical care, and to ensure that clinical trial entry is integrated into core trust business. 6.13. To work with the Research Network and the Northumberland Tyne and Wear Comprehensive Network and the North of England Cancer Network (Service) to enhance and promote research as part of standard patient care. 7. Monitoring and Liaison The Trust will nominate a lead manager for the service provided under this SLA. The contact points for this agreement are: For the Network: For the Trust: North of England Cancer Research Network-North Clinical Lead for Research Research Manager Clinical Lead for Cancer Services and Business R&D Director Manager for Cancer Services 8. Resolution of Disputes Any dispute between the two parties should be resolved by representatives from the Research Network and Trust. Provision of funding is subject to the receipt by the Research Network of a signed copy of this Agreement, and its continuation is contingent upon meeting agreed targets for patient recruitment into NCRN clinical trials. Signed: For and on behalf of the Trust: Name: Mrs Melanie Robertson Signed: Title: Clinical Lead for Cancer Signed: Date: Signed: For and on behalf of the Trust: Name: Denise Inskip Title: Cancer Services Manager Date: Signed: For and on behalf of the Trust: Name: Mr Kim Hinshaw Title: R&D Director Date: For and on behalf of the Research Network: Name: Dr Anne Lennard Title: Clinical Lead North of England Cancer Research Network North Date: Appendix 6 Contact details for Cancer Research Network Team (Clinical Lead for Research and Research Network Manager) (10-5A-101) Clinical Leads for Research North Dr Anne Lennard Freeman Hospital High Heaton Newcastle upon Tyne NE7 7DN Tel: (0191) 2139381 anne.lennard@nuth.nhs.uk PA: Christine Porter Tel: 01642 213 8480 Christine.porter@nuth.nhs.uk South Dr Nick Wadd Academic Centre, The James Cook University Hospital, Marton Road, Middlesbrough TS4 3BW Tel: (01642) 854912 Nick.wadd@stees.nhs.uk PA: Susan Clare Susan.clare@stees.nhs.uk Research Network Managers North Bridget Workman Waterfront 4 Goldcrest Way, Newcastle upon Tyne NE15 8NY Blackberry 07917 554 163 Bridget.Workman@necn.nhs.uk PA: Natalie Hood Tel: 0191 2106502 Natalie.Hood@necn.nhs.uk South Helen Boal Academic Centre, The James Cook University Hospital, Marton Road, Middlesbrough TS4 3BW Direct line (01642) 854122 (internal 54122) PA: Lauren Wilson Tel: 01642 854091 Lauren.wilson@stees.nhs.uk Research Trial Team Leaders Chris Barron - NCCC Sir Bobby Robson Cancer Trials Research Centre, Freeman Hospital, Newcastle NE7 7DN Direct Line (0191) 244 8771 Chris.barron@nuth.nhs.uk Angela Birt - Cumbria Oncology Department, Cumberland Infirmary, Carlisle CA2 7HY Direct Line (01228) 814 397 Mobile 07825 552 517 Angela.birt@ncuh.nhs.uk Alison Chilvers – South Network James Cook University Hospital, Marton Road, Middlesbrough TS4 3BW Direct Line (01642) 835 989 Alison.chilvers@stees.nhs.uk Julia Scott – North Network Waterfront 4, Goldcrest Way, Newcastle upon Tyne, NE15 8NY Blackberry 07795354364 Julia.scott@necn.nhs.uk Local Hospital and Team Contact Details Newcastle Freeman Hospital High Heaton Newcastle upon Tyne Tyne and Wear NE7 7DN Tel: 0191 2336161 Fax: 0191 2131968 Gateshead Health NHS Trust Queen Elizabeth Hospital Gateshead Tyne and Wear NE9 6SX Tel: 0191 4820000 Fax: 0191 4826001 Newcastle Royal Victoria Infirmary Queen Victoria Road Newcastle upon Tyne Tyne and Wear NE1 4LP Tel: 0191 2336161 South Tyneside NHS Foundation Trust Harton Lane South Shields Tyne and Wear NE34 0PL Tel: 0191 4041000 Fax: 0191 2022194 North Tyneside General Hospital Rake Lane North Shields Tyne and Wear NE29 8NH Tel: 0844 811 8111 Fax: 0191 2934162 Wansbeck General Hospital Woodhorn Lane Ashington Northumberland NE63 9JJ Tel: 01670 521212 Fax: 01670 529047 Sunderland Royal Hospital Kayll Road Sunderland Tyne and Wear SR4 7TP Tel: 0191 5656256 University Hospital of North Durham North Road Durham County Durham DH1 5TW Tel: 0191 3332333 Fax: 0191 3332840 The James Cook University Hospital Marton Road Middlesbrough TS4 3BW Tel: 01642 850850 Cumberland Infirmary Newtown Road Carlisle Cumbria CA2 7HY Tel: 01228 523444 Fax: 01228 814380 West Cumberland Hospital Hensingham Whitehaven Cumbria CA28 8JG Tel: 01946 693181 Fax: 01946 523513 University Hospital of North Tees Hardwick Stockton on Tees TS19 8PE Darlington Memorial Hospital Hollyhurst Road Darlington County Durham DL3 6HX Research Staff Job Title Contact Where from Debra Redding Research Radiographer Clinical Trials Coordinator Clinical Trials Officer 0191 2139205 Debra.Redding@nuth.nhs.uk 0191 2138445 Gemma.gills@nuth.nhs.uk 0191 2138439 Jayshree.walker@nuth.nhs.uk 0191 2448774 Jonathan.stoddart@nuth.nhs.uk 0191 2563588 Julie.burton@nuth.nhs.uk 0191 2138435 J.A.Charlton@newcastle.ac.uk 0191 2134839 Lucy.blackwell@nuth.nhs.uk 0191 2138437 Katherine.stevenson@nuth.nhs.uk 0191 2138012 Beth.rodgers@nuth.nhs.uk 0191 2138438 Michelle.borthwick@nuth.nhs.uk 0191 2138437 Irena.holusova@nuth.nhs.uk 0191 2138431 Irene.jobson@nuth.nhs.uk 0191 2137322 or 0191 2448357 Peter.murphy@nuth.nhs.uk 0191 2139288 Sheila.graham2@nuth.nhs.uk 0191 2138321 Steven.ellis@nuth.nhs.uk 0191 2138320 Jamie.brown@nuth.nhs.uk 0191 2137325 Teresa.Lennon@nuth.nhs.uk 0191 2137322 DECT 2448311 Wendy.Robson@nuth.nhs.uk 0191 2563587 Zarine.Razvi@northumbriahealthcare.nhs.uk Newcastle 0191 2934088 Alexis.burn@northumbriahealthcare.nhs.uk 0191 2934163 Ann.wilson@northumbriahealthcare.nhs.uk North Tyneside 0844 8118111 ext 2800 Lynn.mann@northumbriahealthcare.nhs.uk 0191 4452387 Claire.wipat@ghnt.nhs.uk 0191 4452445 Peg.carmody@ghnt.nhs.uk 0191 4452077 or 0191 4820000 Bleep 2638 Rachel.mugnai@ghnt.nhs.uk 0191 4041000 ext 2263 North Tyneside Gemma Gills Jay Walker Jonathan Stoddart Julie Burton Clinical Trials Officer Julie Charlton Senior Sister Manager Lucy Blackwell Data Coordinator Katherine Stevenson Beth Rodgers Clinical Coordinator Data Manager Michelle Borthwick Irena Holusova Data Manager Irene Robson Clinical Trials Associate Urology Research Nurse Haematology Clinical Trials Officer Haematology Data Manager Haematology Data Manager Urology Research Manager Urology Senior Research Nurse Clinical Trials Officer Peter Murphy Sheila Graham Steven Ellis Jamie Brown Teresa Lennon Wendy Robson Zarine Razvi Research Trials Data Manager Alexis Burn Clinical Assistant Trials Ann Wilson Senior Nurse Lynn Mann Clinical Trials Officer Claire Wipat Clinical Trials Officer Peg Carmody Data Manager Rachel Mugnai Research Specialist Judith Moore Clinical Trials Officer Nurse Newcastle Newcastle Newcastle Newcastle Newcastle Newcastle Newcastle Newcastle Newcastle Newcastle Newcastle Newcastle Newcastle Newcastle Newcastle Newcastle Newcastle Wansbeck North Tyneside Gateshead Gateshead Gateshead South Tyneside Vivienne Hullock Data Manager Fiona Callaghan Clinical Trials Officer Paula Newton Haematology Specialist Nurse Jane Cole Haematology Specialist Nurse Lucy Gash Chemo Nurse Judith.moore@stft.nhs.uk 0191 5656256 ext 42329 Vivienne.hullock@chsft.nhs.uk 0191 5656256 ext 42329 Fiona.callaghan@chsft.nhs.uk 0191 5656256 ext 47264 Bleep 52118 Paula.newton@chsft.nhs.uk 0191 5656256 ext 47264 Bleep 52118 Jane.Cole@chsft.nhs.uk Lucy.gash@chsft.nhs.uk Lynn Waugh Chemo Nurse Lynn.waugh@chsft.nhs.uk Sunderland Angela Dixon Chemo Nurse Angela.dixon@chsft.nhs.uk Sunderland Fiona Holdsworth Chemo Nurse Fiona.holdsworth@chsft.nhs.uk Sunderland Andrea Watson Clinical Trials Coordinator Clinical Trials Practitioner Clinical Trials Coordinator Research Radiographer Clinical Trials Assistant Clinical Trials Coordinator Clinical Trials Assistant Clinical Trials Practitioner Clinical Trials Assistant Research Practitioner 01642 282516 Andrea.watson@stees.nhs.uk 01642 282516 Carol.long@stees.nhs.uk 01642 854091 Charlotte.kitching@stees.nhs.uk 01642 854091 Emma.thompson@stees.nhs.uk 01642 835989 Gill.laidlaw@stees.nhs.uk 01642 835568 Karen.chapman@stees.nhs.uk 01642 835568 Paula.milne@stees.nhs.uk 01642 835568 Pam.mclinn@stees.nhs.uk 01642 835989 Rita.mohan@stees.nhs.uk 01228 814397 Charlotte.eyles@ncuh.nhs.uk 01228 814397 Leanne.woodford@ncuh.nhs.uk 01228 814397 Beverley.wilkinson@ncuh.nhs.uk 01228 814397 Patricia.nicholls@ncuh.nhs.uk 01325 280100 ext 4320 Mob: 07990530995 01325 380100 ext 44320 South Tees 0191 3332659 Durham 0191 3332659 Lorna.morgan@cddft.nhs.uk 0191 333 2843 Jean.Dent@cddft.nhs.uk 01325 7443033 Lisa.Godwin@cddft.nhs.uk Durham 0191 3332217 Andrea.Kay@cddft.nhs.uk 0191 3332521 Durham Carol Long Charlotte Kitching Emma Thompson Gill Laidlaw Karen Chapman Paula Milne Pam McLinn Rita Mohan Charlotte Eyles Leanne Woodford Beverley Wilkinson Patricia Nicholls Sue Wadd Hyder Latif Research Radiographer Research Assistant Clinical Research Data Assistant Research Nurse Lorna Morgan Clinical Trials Assistant Clinical Trials Assistant Clinical Trials Officer Jean Dent Research Nurse Lisa Godwin Research Nurse Andrea Kay Research Nurse Lyndsey Taylor Research Nurse Vacant Position Sunderland Sunderland Sunderland Sunderland Sunderland South Tees South Tees South Tees South Tees South Tees South Tees South Tees South Tees Cumbria Cumbria Cumbria Cumbria Darlington Darlington Durham Darlington Durham Durham and Trials Lyndsey.Taylor@cddft.nhs.uk 0191 3332192 Claire.shaw@cddft.nhs.uk 01642 383277 Emma.jameson@nth.nhs.uk 0164 2383277 Clinical Trials Assistant Clinical Trials Practitioner Cancer Research Nurse 01642 383277 Hyder.latif@nth.nhs.uk 01642 383277 Sarah.kiddell@nth.nhs.uk 01642 624524 Deborah.whetter@nth.nhs.uk Claire Shaw Research Nurse Emma Jameson Clinical Assistant Clinical Assistant Helen Wilson Hyder Latif Sarah Kiddell Debbie Whetter Trials Durham North Tees North Tees North Tees North Tees North Tees Appendix 7 Contact Details for Cancer Network Team (Medical Director, Director and Nurse Director) Sarah Rushbrooke and Jane Arthur are contact points for consumer involvement. Role Name Address Director Roy McLachlan Northern Cancer Research Network, North Team Waterfront 4, Goldcrest Way, Newcastle upon Tyne, NE15 8NY Medical Director Dr Tony Branson Northern Cancer Research Network, North Team Waterfront 4, Goldcrest Way, Newcastle upon Tyne, NE15 8NY Medical Lead Dr Nicola Storey Northern Cancer Research Network, North Team Waterfront 4, Goldcrest Way, Newcastle upon Tyne, NE15 8NY Network Quality and Patient Safety Director Sarah Rushbrooke Northern Cancer Research Network, North Team Waterfront 4, Goldcrest Way, Newcastle upon Tyne, NE15 8NY Cancer Modernisation Manager Bill Richardson Northern Cancer Research Network, North Team Waterfront 4, Goldcrest Way, Newcastle upon Tyne, NE15 8NY Cancer Nursing Modernisation Manager Suzanne Thompson Northern Cancer Research Network, North Team Waterfront 4, Goldcrest Way, Newcastle upon Tyne, NE15 8NY Consultant Pharmacist Steve Williams Northern Cancer Research Network, North Team Waterfront 4, Goldcrest Way, Newcastle upon Tyne, NE15 8NY Network Pharmacist Calum Polwart Northern Cancer Research Network, North Team Waterfront 4, Goldcrest Way, Newcastle upon Tyne, NE15 8NY Telephone Tel: 0191 2754733 Tel: 0191 2106566 Tel: 0191 2754698 Tel: 0191 2106559 Tel: 0191 2106521 Tel: 0191 2106548 Tel: 0191 2106568 Tel: 0191 2754709 Email roy.mclachlan@necn.nhs.uk tony.branson@necn.nhs.uk Nicola.storey@stees.nhs.uk sarah.rushbrooke@necn.nhs.uk bill.richardson@necn.nhs.uk Suzanne.Thompson@necn.nhs.uk steve.williams@necn.nhs.uk calum.polwart@necn.nhs.uk Role Name Address Telephone Email Information & Audit Manager Linda Wintersgill Northern Cancer Research Network, North Team Waterfront 4, Goldcrest Way, Newcastle upon Tyne, NE15 8NY Tel: 0191 2754663 linda.wintersgill@necn.nhs.uk Leslie Davie Northern Cancer Research Network, North Team Waterfront 4, Goldcrest Way, Newcastle upon Tyne, NE15 8NY Tel: 0191 2754619 Lesley.davie@necn.nhs.uk AHP Lead Sonia Connors Northern Cancer Research Network, North Team Waterfront 4, Goldcrest Way, Newcastle upon Tyne, NE15 8NY Tel: 0191 2106547 Radiotherapy Project Manager Adrienne Moffett Northern Cancer Research Network, North Team Waterfront 4, Goldcrest Way, Newcastle upon Tyne, NE15 8NY Tel: 0191 2754767 Service Improvement Facilitator Anne Richardson Northern Cancer Research Network, North Team Waterfront 4, Goldcrest Way, Newcastle upon Tyne, NE15 8NY Tel: 0191 2106520 anne.richardson@necn.nhs.uk Service Improvement Facilitator Jo Preston Northern Cancer Research Network, North Team Waterfront 4, Goldcrest Way, Newcastle upon Tyne, NE15 8NY Tel: 0191 2106415 jo.preston@necn.nhs.uk Service Improvement Facilitator Kathryn Jones Northern Cancer Research Network, North Team Waterfront 4, Goldcrest Way, Newcastle upon Tyne, NE15 8NY Tel: 0191 2754778 Toni Hunt Northern Cancer Research Network, North Team Waterfront 4, Goldcrest Way, Newcastle upon Tyne, NE15 8NY Tel: 0191 2754734 Ann Bassom Northern Cancer Research Network, North Team Waterfront 4, Goldcrest Way, Newcastle upon Tyne, NE15 8NY Tel: 0191 2754748 GP Project Manager Service Improvement Facilitator Network Co-ordinator Sonia.connors@necn.nhs.uk Adrienne.moffett@necn.nhs.uk Kath.Jones@necn.nhs.uk Toni.Hunt@necn.nhs.uk ann.bassom@necn.nhs.uk Role Name Address Telephone Email Peer Review Co-ordinator Carol Mayes Northern Cancer Research Network, North Team Waterfront 4, Goldcrest Way, Newcastle upon Tyne, NE15 8NY Tel: 0191 2754743 carol.mayes@necn.nhs.uk Information Analyst Elaine Robinson Northern Cancer Research Network, North Team Waterfront 4, Goldcrest Way, Newcastle upon Tyne, NE15 8NY Tel: 0191 2106525 Chris Young Northern Cancer Research Network, North Team Waterfront 4, Goldcrest Way, Newcastle upon Tyne, NE15 8NY Tel: 0191 2754780 Helen Douglas Northern Cancer Research Network, North Team Waterfront 4, Goldcrest Way, Newcastle upon Tyne, NE15 8NY Tel: 0191 2754698 Administrator Claire McNeill Northern Cancer Research Network, North Team Waterfront 4, Goldcrest Way, Newcastle upon Tyne, NE15 8NY Tel: 0191 2754608 Administrator Angela Wheaton Northern Cancer Research Network, North Team Waterfront 4, Goldcrest Way, Newcastle upon Tyne, NE15 8NY Tel: 0191 2754787 Information Analyst Network PA elaine.robinson@necn.nhs.uk Chris.young@necn.nhs.uk helen.douglas@necn.nhs.uk claire.mcneil@necn.nhs.uk Angela.wheaton@necn.nhs.uk Appendix 8 Contact Details for Leads for each cancer site corresponding to NCRI Clinical Study (Development) Groups Name of Group Sarcoma Advisory Group Chair Shona Murray Vice Chair Email Address shona.murray@nuth.nhs.uk Telephone 0191 2336161 Brain & Central Nervous System Philip Kane John Crossman philip.kane@stees.nhs.uk john.crossman@nuth.nhs.uk 01642 850850 0191 2336161 Breast Linsley Lunt Mark Verrill linsley.lunt@ghnt.nhs.uk mark.verrill@nuth.nhs.uk 0191 4820000 Children & Young People Juliet Hale Scott Marshall Juliet.hale@nuth.nhs.uk s.marshall@ghnt.nhs.uk 0191 2336161 0191 4820000 Chemotherapy Steve Williamson Steve.williamson@nhct.nhs.uk 0844 8118111 Colorectal Talvinder Gill Talvinder.gill@nth.nhs.uk 01642 617617 Genetics Fiona Douglas Alex Henderson fiona.douglas@nuth.nhs.uk alex.henderson@nuth.nhs.uk 0191 2336161 0191 2336161 Gynae-Oncology Neil Hebblethwaite Richard Edmondson neil.hebblethwaite@stees.nhs.uk richard.edmondson@ghnt.nhs.uk 01642 850850 0191 4820000 Haematology Victory Hervey Gail Jones Victoria.Hervey@chsft.nhs.uk Gail.jones@nuth.nhs.uk 0191 5656256 0191 2336161 Head & Neck Doug Bryant Jim Moor douglas.bryant@stees.nhs.uk james.moor@chsft.nhs.uk 01642 850850 0191 5656256 Histopathology Paul Barrett paul.barrett@cddft.nhs.uk 01325 380100 HPB Bryon Jaques Steve White Bryon.jaques@nuth.nhs.uk steve.white@nuth.nhs.uk 0191 2336161 0191 2336161 Lung Leslie Mitchell Sion Barnard Leslie.mitchell@nuth.nhs.uk Sion.barnard@nuth.nhs.uk 0191 2336161 MSCC Charles Greenough charles.greenough@stees.nhs.uk 01642 850850 NAOG Nicola Storey Chris Jones Nicola.storey@stees.nhs.uk Christopher.Jones@nuth.nhs.uk 01642 850850 0191 2336161 OG Sam Dresner Nick Hayes sam.dresner@stees.nhs.uk nick.hayes@nuth.nhs.uk 01642 850850 0191 2336161 Primary Care Duncan Leith Robin Armstrong Duncan.leith@GP-A84025.nhs.uk Robin.armstrong@nhs.net 01670 713911 0191 586 4331 Radiology Matthew Trewhella matthew.trewhella@nth.nhs.uk 01642 617617 Radiotherapy Chris Walker Sandeep Singhal Chris.walker@stees.nhs.uk 0191 2336161 sandeep.singhal@ncumbria-acute.nhs.uk 01228 523444 Skin James Langtry Keith Allison james.langtry@nuth.nhs.uk keith.allison@stees.nhs.uk 0191 2336161 01642 850850 Supportive & Palliative Alison Featherstone Care Steering Group AFeatherstone@macmillan.org.uk Thyroid Sath Nag sath.nag@stees.nhs.uk 01642 850850 Urology Mark Johnson mark.johnsonnuth.nhs.uk 0191 2336161 Appendix 9 Network Clinicians who are members of NCRI Clinical Study (Development) Groups Clinical Studies Group Name Area Newcastle Institution Sarcoma Mr. Craig Gerrand Department of Orthopedics Gynecological Dr Raj Naik Gateshead Queen Elizabeth Hospital Gynecological Mr. Richard Edmondson Gateshead Northern Gynecological Oncology Centre Biomarker and Imaging Professor Craig Robson Newcastle Northern institute for Cancer Research, Newcastle University Bladder Mr. Mark Johnson Newcastle Freeman Hospital Lymphoma Mr. David Rabjohns Newcastle Lymphoma Dr Anne Lennard Newcastle Melanoma Professor Ruth Plummer Newcastle Prostate Mr. Garrett Durkan Newcastle Freeman Hospital Northern Institute for Cancer Research Newcastle University Freeman Hospital Renal Mr. Naeem Soomro Newcastle Freeman Hospital Sarcoma Dr Ross Maxwell Newcastle Newcastle General Hospital Testis Dr Rhona M McMenemin Newcastle Northern Centre for Cancer Treatment Melanoma Dr Charles Kelly Newcastle Northern Centre for Cancer Treatment Breast Mr. Obi Iwuchukwu Sunderland Sunderland Royal Hospital Primary Care Professor Greg Rubin Sunderland Durham University Prostate Mr. Damian Greene Sunderland Sunderland Royal University Hospital Upper GI Mr. David Watson Chester-le-Street Consumer Palliative Care Ms Margaret Ogden Sedgefield Consumer Lymphoma Mr. David Rabjohns Newcastle Consumer Appendix 10 Comprehensive Local Research Network Directors and Senior Managers The County Durham and Tees Valley Comprehensive Local Research Network (CLRN) Clinical Director Dr Sam Eldabe Senior Manager Lorraine Atkinson Lead RM&G Manager Sharon Dorgan. Information Manager Ian Johansson Administrator Rebecca Hall Industry Manager Vicky Hawkins Research Team Leader Dr Steve Pratt The Cumbria and Lancashire Comprehensive Local Research Network (CLRN) CLRN Director Senior Manager Lead RM&G Manager Information Manager CLRN Administrator Professor John Goodacre John Wardle Jillian Martin Jonathan Aitchison Margaret Johnson The Northumberland, Tyne and Wear Comprehensive Local Research Network (CLRN) Clinical Director Senior Manager Lead RM&G Manager Industry Manager Information Manager Project Manager Professor Stephen Robson Dr Séamus O’Neill Ms Justine Smith Ms Karen Huchinson Miss Lestryne Clift Mr. Mark Ryan-Daly Appendix 11 NECRN-N Host Organisation The Service Network and NECRN–N are hosted by South Tyneside PCT and the NECRN-N Research Manager is based with the NECN team at Waterfront 4 Newcastle The contact for the host organisation is: Chief Executive: Karen Straughair Address: South Tyneside PCT, Pemberton House Colima Avenue Sunderland Enterprise Park Sunderland SR5 3XB Tel: 0191 5297003 Email: Website: enquiries@stpct.nhs.uk South Tyneside PCT website
